Molecular Regulation of Cellular Senescence by MicroRNAs: Implications in Cancer and Age-Related Diseases

International Review of Cell and Molecular Biology

Volumn 334, Issue , 2018, Pages 27-98

  Neault, Mathieu ^a,b   Couteau, Florence ^a   Bonneau, Éric ^c   De Guire, Vincent ^b,c   Mallette, Frédérick A ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

Aging; Cancer; Cellular senescence; MiR; p53; RB

Indexed keywords

BETA GALACTOSIDASE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; HIGH MOBILITY GROUP A2 PROTEIN; MICRORNA; MICRORNA 34; MIRAVIRSEN; PROTEIN P16; PROTEIN P21; PROTEIN P53; SIRTUIN 1; TELOMERASE; TEMAVIRSEN; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

AUTOPHAGY; AUTOREGULATION; BIOGENESIS; CELL AGING; CELL CYCLE ARREST; CELL CYCLE CHECKPOINT; CELL MATURATION; CELL NUCLEUS MEMBRANE; CELL TRANSFORMATION; CHROMATIN CONDENSATION; DEGENERATIVE DISEASE; DNA DAMAGE RESPONSE; DNA METHYLATION; ENZYME ACTIVATION; ENZYME ACTIVITY; FEEDBACK SYSTEM; GENE EXPRESSION; GENE LOCUS; GENE REPRESSION; GENOMIC INSTABILITY; HETEROCHROMATIN; HISTONE METHYLATION; HUMAN; LIFESPAN; MALIGNANT NEOPLASM; MAPK SIGNALING; MUSCULOSKELETAL DISEASE; NONHUMAN; PHENOTYPE; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; REGULATORY MECHANISM; TELOMERE; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; UPREGULATION; AGING; ANIMAL; GENETICS; METABOLISM; NEOPLASM; SIGNAL TRANSDUCTION;

AGING; ANIMALS; BIOMARKERS; CELLULAR SENESCENCE; HUMANS; MICRORNAS; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 85019357274     PISSN: 19376448     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.ircmb.2017.04.001     Document Type: Chapter

References (440)

1. Abdelmohsen, K., Pullmann, R. Jr., Lal, A., Kim, H.H., Galban, S., Yang, X., Blethrow, J.D., Walker, M., Shubert, J., Gillespie, D.A., Furneaux, H., Gorospe, M., Phosphorylation of HuR by Chk2 regulates SIRT1 expression. Mol. Cell 25 (2007), 543–557.
2. Abdelmohsen, K., Srikantan, S., Kuwano, Y., Gorospe, M., miR-519 reduces cell proliferation by lowering RNA-binding protein HuR levels. Proc. Natl. Acad. Sci. U.S.A. 105 (2008), 20297–20302.
3. Acosta, J.C., O'loghlen, A., Banito, A., Guijarro, M.V., Augert, A., Raguz, S., Fumagalli, M., Da Costa, M., Brown, C., Popov, N., Takatsu, Y., Melamed, J., D'adda Di Fagagna, F., Bernard, D., Hernando, E., Gil, J., Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 133 (2008), 1006–1018.
4. Acosta, J.C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J.P., Athineos, D., Kang, T.W., Lasitschka, F., Andrulis, M., Pascual, G., Morris, K.J., Khan, S., Jin, H., Dharmalingam, G., Snijders, A.P., Carroll, T., Capper, D., Pritchard, C., Inman, G.J., Longerich, T., Sansom, O.J., Benitah, S.A., Zender, L., Gil, J., A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat. Cell Biol. 15 (2013), 978–990.
5. Adams, B.D., Parsons, C., Slack, F.J., The tumor-suppressive and potential therapeutic functions of miR-34a in epithelial carcinomas. Expert Opin. Ther. Targets 20 (2016), 737–753.
6. Adams, B.D., Wali, V.B., Cheng, C.J., Inukai, S., Booth, C.J., Agarwal, S., Rimm, D.L., Gyorffy, B., Santarpia, L., Pusztai, L., Saltzman, W.M., Slack, F.J., miR-34a silences c-SRC to attenuate tumor growth in triple-negative breast cancer. Cancer Res. 76 (2016), 927–939.
7. Akman, B.H., Can, T., Erson-Bensan, A.E., Estrogen-induced upregulation and 3’-UTR shortening of CDC6. Nucleic Acids Res. 40 (2012), 10679–10688.
8. Alexander, K., Yang, H.S., Hinds, P.W., Cellular senescence requires CDK5 repression of Rac1 activity. Mol. Cell. Biol. 24 (2004), 2808–2819.
9. Alexandrov, P.N., Dua, P., Hill, J.M., Bhattacharjee, S., Zhao, Y., Lukiw, W.J., microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF). Int. J. Biochem. Mol. Biol. 3 (2012), 365–373.
10. Alexandrov, P.N., Dua, P., Lukiw, W.J., Up-regulation of miRNA-146a in progressive, age-related inflammatory neurodegenerative disorders of the human CNS. Front. Neurol., 5, 2014, 181.
11. Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., Wood, M.J., Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol. 29 (2011), 341–345.
12. Ambati, J., Ambati, B.K., Yoo, S.H., Ianchulev, S., Adamis, A.P., Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv. Ophthalmol. 48 (2003), 257–293.
13. Ambs, S., Prueitt, R.L., Yi, M., Hudson, R.S., Howe, T.M., Petrocca, F., Wallace, T.A., Liu, C.G., Volinia, S., Calin, G.A., Yfantis, H.G., Stephens, R.M., Croce, C.M., Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res. 68 (2008), 6162–6170.
14. Araldi, E., Schipani, E., MicroRNA-140 and the silencing of osteoarthritis. Genes Dev. 24 (2010), 1075–1080.
15. Aranha, M.M., Santos, D.M., Sola, S., Steer, C.J., Rodrigues, C.M., miR-34a regulates mouse neural stem cell differentiation. PLoS One, 6, 2011, e21396.
16. Arroyo, J.D., Chevillet, J.R., Kroh, E.M., Ruf, I.K., Pritchard, C.C., Gibson, D.F., Mitchell, P.S., Bennett, C.F., Pogosova-Agadjanyan, E.L., Stirewalt, D.L., Tait, J.F., Tewari, M., Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc. Natl. Acad. Sci. U.S.A. 108 (2011), 5003–5008.
17. Astle, M.V., Hannan, K.M., Ng, P.Y., Lee, R.S., George, A.J., Hsu, A.K., Haupt, Y., Hannan, R.D., Pearson, R.B., AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancy. Oncogene 31 (2012), 1949–1962.
18. Aylon, Y., Michael, D., Shmueli, A., Yabuta, N., Nojima, H., Oren, M., A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization. Genes Dev. 20 (2006), 2687–2700.
19. Bae, Y., Yang, T., Zeng, H.C., Campeau, P.M., Chen, Y., Bertin, T., Dawson, B.C., Munivez, E., Tao, J., Lee, B.H., miRNA-34c regulates Notch signaling during bone development. Hum. Mol. Genet. 21 (2012), 2991–3000.
20. Baek, J., Kang, S., Min, H., MicroRNA-targeting therapeutics for hepatitis C. Arch. Pharm. Res. 37 (2014), 299–305.
21. Bagchi, A., Papazoglu, C., Wu, Y., Capurso, D., Brodt, M., Francis, D., Bredel, M., Vogel, H., Mills, A.A., CHD5 is a tumor suppressor at human 1p36. Cell 128 (2007), 459–475.
22. Baker, D.J., Wijshake, T., Tchkonia, T., Lebrasseur, N.K., Childs, B.G., Van De Sluis, B., Kirkland, J.L., Van Deursen, J.M., Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479 (2011), 232–236.
23. Baker, D.J., Childs, B.G., Durik, M., Wijers, M.E., Sieben, C.J., Zhong, J., Saltness, R.A., Jeganathan, K.B., Verzosa, G.C., Pezeshki, A., Khazaie, K., Miller, J.D., Van Deursen, J.M., Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan. Nature 530 (2016), 184–189.
24. Bao, J., Li, D., Wang, L., Wu, J., Hu, Y., Wang, Z., Chen, Y., Cao, X., Jiang, C., Yan, W., Xu, C., MicroRNA-449 and microRNA-34b/c function redundantly in murine testes by targeting E2F transcription factor-retinoblastoma protein (E2F-pRb) pathway. J. Biol. Chem. 287 (2012), 21686–21698.
25. Bargaje, R., Gupta, S., Sarkeshik, A., Park, R., Xu, T., Sarkar, M., Halimani, M., Roy, S.S., Yates, J., Pillai, B., Identification of novel targets for miR-29a using miRNA proteomics. PLoS One, 7, 2012, e43243.
26. Barski, A., Cuddapah, S., Cui, K., Roh, T.Y., Schones, D.E., Wang, Z., Wei, G., Chepelev, I., Zhao, K., High-resolution profiling of histone methylations in the human genome. Cell 129 (2007), 823–837.
27. Bartel, D.P., MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116 (2004), 281–297.
28. Bartel, D.P., MicroRNAs: target recognition and regulatory functions. Cell 136 (2009), 215–233.
29. Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.V.F., Kolettas, E., Niforou, K., Zoumpourlis, V.C., Takaoka, M., Nakagawa, H., Tort, F., Fugger, K., Johansson, F., Sehested, M., Andersen, C.L., Dyrskjot, L., Orntoft, T., Lukas, J., Kittas, C., Helleday, T., Halazonetis, T.D., Bartek, J., Gorgoulis, V.G., Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444 (2006), 633–637.
30. Bates, S., Phillips, A.C., Clark, P.A., Stott, F., Peters, G., Ludwig, R.L., Vousden, K.H., p14ARF links the tumour suppressors RB and p53. Nature 395 (1998), 124–125.
31. Batistela, M.S., Josviak, N.D., Sulzbach, C.D., De Souza, R.L., An overview of circulating cell-free microRNAs as putative biomarkers in Alzheimer's and Parkinson's diseases. Int. J. Neurosci. 127 (2017), 547–558.
32. Baylin, S.B., Ohm, J.E., Epigenetic gene silencing in cancer—a mechanism for early oncogenic pathway addiction?. Nat. Rev. Cancer 6 (2006), 107–116.
33. Beausejour, C.M., Krtolica, A., Galimi, F., Narita, M., Lowe, S.W., Yaswen, P., Campisi, J., Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J. 22 (2003), 4212–4222.
34. Beckerman, R., Prives, C., Transcriptional regulation by p53. Cold Spring Harb. Perspect. Biol., 2, 2010, a000935.
35. Bemis, L.T., Chen, R., Amato, C.M., Classen, E.H., Robinson, S.E., Coffey, D.G., Erickson, P.F., Shellman, Y.G., Robinson, W.A., MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines. Cancer Res. 68 (2008), 1362–1368.
36. Benevolenskaya, E.V., Histone H3K4 demethylases are essential in development and differentiation. Biochem. Cell Biol. 85 (2007), 435–443.
37. Benhamed, M., Herbig, U., Ye, T., Dejean, A., Bischof, O., Senescence is an endogenous trigger for microRNA-directed transcriptional gene silencing in human cells. Nat. Cell Biol. 14 (2012), 266–275.
38. Bentwich, I., Avniel, A., Karov, Y., Aharonov, R., Gilad, S., Barad, O., Barzilai, A., Einat, P., Einav, U., Meiri, E., Sharon, E., Spector, Y., Bentwich, Z., Identification of hundreds of conserved and nonconserved human microRNAs. Nat. Genet. 37 (2005), 766–770.
39. Berber, P., Grassmann, F., Kiel, C., Weber, B.H., An eye on age-related macular degeneration: the role of MicroRNAs in disease pathology. Mol. Diagn. Ther. 21 (2017), 31–43.
40. Beyer, I., Njemini, R., Bautmans, I., Demanet, C., Bergmann, P., Mets, T., Inflammation-related muscle weakness and fatigue in geriatric patients. Exp. Gerontol. 47 (2012), 52–59.
41. Bhatnagar, S., Chertkow, H., Schipper, H.M., Yuan, Z., Shetty, V., Jenkins, S., Jones, T., Wang, E., Increased microRNA-34c abundance in Alzheimer's disease circulating blood plasma. Front. Mol. Neurosci., 7, 2014, 2.
42. Bhattacharyya, S.N., Habermacher, R., Martine, U., Closs, E.I., Filipowicz, W., Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell 125 (2006), 1111–1124.
43. Bhaumik, D., Scott, G.K., Schokrpur, S., Patil, C.K., Orjalo, A.V., Rodier, F., Lithgow, G.J., Campisi, J., MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8. Aging (Albany NY) 1 (2009), 402–411.
44. Blow, J.J., Hodgson, B., Replication licensing—defining the proliferative state?. Trends Cell Biol. 12 (2002), 72–78.
45. Bohnsack, M.T., Czaplinski, K., Gorlich, D., Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs. RNA 10 (2004), 185–191.
46. Bommer, G.T., Gerin, I., Feng, Y., Kaczorowski, A.J., Kuick, R., Love, R.E., Zhai, Y., Giordano, T.J., Qin, Z.S., Moore, B.B., Macdougald, O.A., Cho, K.R., Fearon, E.R., p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr. Biol. 17 (2007), 1298–1307.
47. Bonci, D., Coppola, V., Musumeci, M., Addario, A., Giuffrida, R., Memeo, L., D'urso, L., Pagliuca, A., Biffoni, M., Labbaye, C., Bartucci, M., Muto, G., Peschle, C., De Maria, R., The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat. Med. 14 (2008), 1271–1277.
48. Bond, J.A., Wyllie, F.S., Wynfordthomas, D., Escape from senescence in human-diploid fibroblasts induced directly by mutant p53. Oncogene 9 (1994), 1885–1889.
49. Borgdorff, V., Lleonart, M.E., Bishop, C.L., Fessart, D., Bergin, A.H., Overhoff, M.G., Beach, D.H., Multiple microRNAs rescue from Ras-induced senescence by inhibiting p21(Waf1/Cip1). Oncogene 29 (2010), 2262–2271.
50. Bouchie, A., First microRNA mimic enters clinic. Nat. Biotechnol., 31, 2013, 577.
51. Bracken, A.P., Kleine-Kohlbrecher, D., Dietrich, N., Pasini, D., Gargiulo, G., Beekman, C., Theilgaard-Monch, K., Minucci, S., Porse, B.T., Marine, J.C., Hansen, K.H., Helin, K., The polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev. 21 (2007), 525–530.
52. Braig, M., Lee, S., Loddenkemper, C., Rudolph, C., Peters, A.H., Schlegelberger, B., Stein, H., Dorken, B., Jenuwein, T., Schmitt, C.A., Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436 (2005), 660–665.
53. Brengues, M., Teixeira, D., Parker, R., Movement of eukaryotic mRNAs between polysomes and cytoplasmic processing bodies. Science 310 (2005), 486–489.
54. Brown, J.P., Wei, W.Y., Sedivy, J.M., Bypass of senescence after disruption of p21(CIP1/WAF1) gene in normal diploid human fibroblasts. Science 277 (1997), 831–834.
55. Bueno, M.J., Gomez De Cedron, M., Laresgoiti, U., Fernandez-Piqueras, J., Zubiaga, A.M., Malumbres, M., Multiple E2F-induced microRNAs prevent replicative stress in response to mitogenic signaling. Mol. Cell. Biol. 30 (2010), 2983–2995.
56. Bulavin, D.V., Kovalsky, O., Hollander, M.C., Fornace, A.J., Loss of oncogenic H-ras-induced cell cycle arrest and p38 mitogen-activated protein kinase activation by disruption of gadd45a. Mol. Cell. Biol. 23 (2003), 3859–3871.
57. Burkhart, D.L., Sage, J., Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat. Rev. Cancer 8 (2008), 671–682.
58. Burma, S., Chen, B.P., Murphy, M., Kurimasa, A., Chen, D.J., ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J. Biol. Chem. 276 (2001), 42462–42467.
59. Carbonneau, M., M. Gagné L., Lalonde, M.E., Germain, M.A., Motorina, A., Guiot, M.C., Secco, B., Vincent, E.E., Tumber, A., Hulea, L., Bergeman, J., Oppermann, U., Jones, R.G., Laplante, M., Topisirovic, I., Petrecca, K., Huot, M.E., Mallette, F.A., The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway. Nat. Commun., 7, 2016, 12700.
60. Carnero, A., Hudson, J.D., Hannon, G.J., Beach, D.H., Loss-of-function genetics in mammalian cells: the p53 tumor suppressor model. Nucleic Acids Res. 28 (2000), 2234–2241.
61. Carrier, F., Smith, M.L., Bae, I., Kilpatrick, K.E., Lansing, T.J., Chen, C.Y., Engelstein, M., Friend, S.H., Henner, W.D., Gilmer, T.M., et al. Characterization of human Gadd45, a p53-regulated protein. J. Biol. Chem. 269 (1994), 32672–32677.
62. Chan, E.Y., Kir, S., Tooze, S.A., siRNA screening of the kinome identifies ULK1 as a multidomain modulator of autophagy. J. Biol. Chem. 282 (2007), 25464–25474.
63. Chang, T.C., Wentzel, E.A., Kent, O.A., Ramachandran, K., Mullendore, M., Lee, K.H., Feldmann, G., Yamakuchi, M., Ferlito, M., Lowenstein, C.J., Arking, D.E., Beer, M.A., Maitra, A., Mendell, J.T., Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol. Cell 26 (2007), 745–752.
64. Chang, Y.C., Jan, C.I., Peng, C.Y., Lai, Y.C., Hu, F.W., Yu, C.C., Activation of microRNA-494-targeting Bmi1 and ADAM10 by silibinin ablates cancer stemness and predicts favourable prognostic value in head and neck squamous cell carcinomas. Oncotarget 6 (2015), 24002–24016.
65. Chellappan, S.P., Hiebert, S., Mudryj, M., Horowitz, J.M., Nevins, J.R., The E2F transcription factor is a cellular target for the RB protein. Cell 65 (1991), 1053–1061.
66. Chen, L., Gilkes, D.M., Pan, Y., Lane, W.S., Chen, J., ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage. EMBO J. 24 (2005), 3411–3422.
67. Chen, Z., Trotman, L.C., Shaffer, D., Lin, H.K., Dotan, Z.A., Niki, M., Koutcher, J.A., Scher, H.I., Ludwig, T., Gerald, W., Cordon-Cardo, C., Pandolfi, P.P., Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436 (2005), 725–730.
68. Chen, L., Wang, X., Wang, H., Li, Y., Yan, W., Han, L., Zhang, K., Zhang, J., Wang, Y., Feng, Y., Pu, P., Jiang, T., Kang, C., Jiang, C., miR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2. Eur. J. Cancer 48 (2012), 3104–3111.
69. Chen, D., Xia, D., Pan, Z., Xu, D., Zhou, Y., Wu, Y., Cai, N., Tang, Q., Wang, C., Yan, M., Zhang, J.J., Zhou, K., Wang, Q., Feng, Y., Wang, X., Xu, H., Zhang, X., Tian, N., Metformin protects against apoptosis and senescence in nucleus pulposus cells and ameliorates disc degeneration in vivo. Cell Death Dis., 7, 2016, e2441.
70. Cheng, A.M., Byrom, M.W., Shelton, J., Ford, L.P., Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res. 33 (2005), 1290–1297.
71. Childs, B.G., Durik, M., Baker, D.J., Van Deursen, J.M., Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nat. Med. 21 (2015), 1424–1435.
72. Childs, B.G., Baker, D.J., Wijshake, T., Conover, C.A., Campisi, J., Van Deursen, J.M., Senescent intimal foam cells are deleterious at all stages of atherosclerosis. Science 354 (2016), 472–477.
73. Chin, L.J., Ratner, E., Leng, S.G., Zhai, R.H., Nallur, S., Babar, I., Muller, R.U., Straka, E., Su, L., Burki, E.A., Crowell, R.E., Patel, R., Kulkarni, T., Homer, R., Zelterman, D., Kidd, K.K., Zhu, Y., Christiani, D.C., Belinsky, S.A., Slack, F.J., Weidhaas, J.B., A SNP in a let-7 microRNA complementary site in the KRAS 3’ untranslated region increases non-small cell lung cancer risk. Cancer Res. 68 (2008), 8535–8540.
74. Chinta, S.J., Lieu, C.A., Demaria, M., Laberge, R.M., Campisi, J., Andersen, J.K., Environmental stress, ageing and glial cell senescence: a novel mechanistic link to Parkinson's disease?. J. Intern. Med. 273 (2013), 429–436.
75. Chinta, S.J., Woods, G., Rane, A., Demaria, M., Campisi, J., Andersen, J.K., Cellular senescence and the aging brain. Exp. Gerontol. 68 (2015), 3–7.
76. Chiosea, S., Jelezcova, E., Chandran, U., Acquafondata, M., Mchale, T., Sobol, R.W., Dhir, R., Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma. Am. J. Pathol. 169 (2006), 1812–1820.
77. Chiosea, S., Jelezcova, E., Chandran, U., Luo, J., Mantha, G., Sobol, R.W., Dacic, S., Overexpression of Dicer in precursor lesions of lung adenocarcinoma. Cancer Res. 67 (2007), 2345–2350.
78. Choi, Y.J., Lin, C.P., Ho, J.J., He, X., Okada, N., Bu, P., Zhong, Y., Kim, S.Y., Bennett, M.J., Chen, C., Ozturk, A., Hicks, G.G., Hannon, G.J., He, L., miR-34 miRNAs provide a barrier for somatic cell reprogramming. Nat. Cell Biol. 13 (2011), 1353–1360.
79. Chowdhury, D., Choi, Y.E., Brault, M.E., DNA damage. Opinion: charity begins at home: non-coding RNA functions in DNA repair. Nat. Rev. Mol. Cell Biol. 14 (2013), 181–189.
80. Christoffersen, N.R., Shalgi, R., Frankel, L.B., Leucci, E., Lees, M., Klausen, M., Pilpel, Y., Nielsen, F.C., Oren, M., Lund, A.H., p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC. Cell Death Differ. 17 (2010), 236–245.
81. Christopher, A.F., Kaur, R.P., Kaur, G., Kaur, A., Gupta, V., Bansal, P., MicroRNA therapeutics: discovering novel targets and developing specific therapy. Perspect. Clin. Res. 7 (2016), 68–74.
82. Chuang, J.C., Jones, P.A., Epigenetics and microRNAs. Pediatr. Res. 61 (2007), 24R–29R.
83. Cirera-Salinas, D., Pauta, M., Allen, R.M., Salerno, A.G., Ramirez, C.M., Chamorro-Jorganes, A., Wanschel, A.C., Lasuncion, M.A., Morales-Ruiz, M., Suarez, Y., Baldan, A., Esplugues, E., Fernandez-Hernando, C., Mir-33 regulates cell proliferation and cell cycle progression. Cell Cycle 11 (2012), 922–933.
84. Cogswell, J.P., Ward, J., Taylor, I.A., Waters, M., Shi, Y., Cannon, B., Kelnar, K., Kemppainen, J., Brown, D., Chen, C., Prinjha, R.K., Richardson, J.C., Saunders, A.M., Roses, A.D., Richards, C.A., Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J. Alzheimers Dis. 14 (2008), 27–41.
85. Collado, M., Serrano, M., The power and the promise of oncogene-induced senescence markers. Nat. Rev. Cancer 6 (2006), 472–476.
86. Collado, M., Serrano, M., Senescence in tumours: evidence from mice and humans. Nat. Rev. Cancer 10 (2010), 51–57.
87. Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A.J., Barradas, M., Benguria, A., Zaballos, A., Flores, J.M., Barbacid, M., Beach, D., Serrano, M., Tumour biology: senescence in premalignant tumours. Nature, 436, 2005, 642.
88. Concepcion, C.P., Han, Y.C., Mu, P., Bonetti, C., Yao, E., D'andrea, A., Vidigal, J.A., Maughan, W.P., Ogrodowski, P., Ventura, A., Intact p53-dependent responses in miR-34-deficient mice. PLoS Genet., 8, 2012, e1002797.
89. Cong, Y.S., Wright, W.E., Shay, J.W., Human telomerase and its regulation. Microbiol. Mol. Biol. Rev. 66 (2002), 407–425 table of contents.
90. Connor, K.M., Krah, N.M., Dennison, R.J., Aderman, C.M., Chen, J., Guerin, K.I., Sapieha, P., Stahl, A., Willett, K.L., Smith, L.E., Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nat. Protoc. 4 (2009), 1565–1573.
91. Coppe, J.P., Desprez, P.Y., Krtolica, A., Campisi, J., The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol. 5 (2010), 99–118.
92. Corney, D.C., Hwang, C.I., Matoso, A., Vogt, M., Flesken-Nikitin, A., Godwin, A.K., Kamat, A.A., Sood, A.K., Ellenson, L.H., Hermeking, H., Nikitin, A.Y., Frequent downregulation of miR-34 family in human ovarian cancers. Clin. Cancer Res. 16 (2010), 1119–1128.
93. Croce, C.M., Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 10 (2009), 704–714.
94. Cruz, F.M., Tome, M., Bernal, J.A., Bernad, A., miR-300 mediates Bmi1 function and regulates differentiation in primitive cardiac progenitors. Cell Death Dis., 6, 2015, e1953.
95. Cui, J.G., Li, Y.Y., Zhao, Y., Bhattacharjee, S., Lukiw, W.J., Differential regulation of interleukin-1 receptor-associated kinase-1 (IRAK-1) and IRAK-2 by microRNA-146a and NF-kappaB in stressed human astroglial cells and in Alzheimer disease. J. Biol. Chem. 285 (2010), 38951–38960.
96. De Guire, V., Robitaille, R., Tetreault, N., Guerin, R., Menard, C., Bambace, N., Sapieha, P., Circulating miRNAs as sensitive and specific biomarkers for the diagnosis and monitoring of human diseases: promises and challenges. Clin. Biochem. 46 (2013), 846–860.
97. De Stanchina, E., Querido, E., Narita, M., Davuluri, R.V., Pandolfi, P.P., Ferbeyre, G., Lowe, S.W., PML is a direct p53 target that modulates p53 effector functions. Mol. Cell 13 (2004), 523–535.
98. Deer, E.L., Gonzalez-Hernandez, J., Coursen, J.D., Shea, J.E., Ngatia, J., Scaife, C.L., Firpo, M.A., Mulvihill, S.J., Phenotype and genotype of pancreatic cancer cell lines. Pancreas 39 (2010), 425–435.
99. Degregori, J., Leone, G., Ohtani, K., Miron, A., Nevins, J.R., E2F-1 accumulation bypasses a G1 arrest resulting from the inhibition of G1 cyclin-dependent kinase activity. Genes Dev. 9 (1995), 2873–2887.
100. Demaria, M., Ohtani, N., Youssef, S.A., Rodier, F., Toussaint, W., Mitchell, J.R., Laberge, R.M., Vijg, J., Van Steeg, H., Dolle, M.E., Hoeijmakers, J.H., De Bruin, A., Hara, E., Campisi, J., An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. Dev. Cell 31 (2014), 722–733.
101. Denis, H., Ndlovu, M.N., Fuks, F., Regulation of mammalian DNA methyltransferases: a route to new mechanisms. EMBO Rep. 12 (2011), 647–656.
102. Denk, J., Boelmans, K., Siegismund, C., Lassner, D., Arlt, S., Jahn, H., MicroRNA profiling of CSF reveals potential biomarkers to detect Alzheimer's disease. PLoS One, 10, 2015, e0126423.
103. Denoyelle, C., Abou-Rjaily, G., Bezrookove, V., Verhaegen, M., Johnson, T.M., Fullen, D.R., Pointer, J.N., Gruber, S.B., Su, L.D., Nikiforov, M.A., Kaufman, R.J., Bastian, B.C., Soengas, M.S., Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway. Nat. Cell Biol. 8 (2006), 1053–1063.
104. Deschenes-Simard, X., Gaumont-Leclerc, M.F., Bourdeau, V., Lessard, F., Moiseeva, O., Forest, V., Igelmann, S., Mallette, F.A., Saba-El-Leil, M.K., Meloche, S., Saad, F., Mes-Masson, A.M., Ferbeyre, G., Tumor suppressor activity of the ERK/MAPK pathway by promoting selective protein degradation. Genes Dev. 27 (2013), 900–915.
105. Di Fagagna, F.D., Reaper, P.M., Clay-Farrace, L., Fiegler, H., Carr, P., Von Zglinicki, T., Saretzki, G., Carter, N.P., Jackson, S.P., A DNA damage checkpoint response in telomere-initiated senescence. Nature 426 (2003), 194–198.
106. Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre, M., Nuciforo, P.G., Bensimon, A., Maestro, R., Pelicci, P.G., Di Fagagna, F.D., Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444 (2006), 638–642.
107. Dimmeler, S., Nicotera, P., MicroRNAs in age-related diseases. EMBO Mol. Med. 5 (2013), 180–190.
108. Dimozi, A., Mavrogonatou, E., Sklirou, A., Kletsas, D., Oxidative stress inhibits the proliferation, induces premature senescence and promotes a catabolic phenotype in human nucleus pulposus intervertebral disc cells. Eur. Cell. Mater. 30 (2015), 89–102 discussion 103.
109. Dimri, G.P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E.E., Linskens, M., Rubelj, I., Pereira-Smith, O., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. U.S.A. 92 (1995), 9363–9367.
110. Dimri, M., Carroll, J.D., Cho, J.H., Dimri, G.P., microRNA-141 regulates BMI1 expression and induces senescence in human diploid fibroblasts. Cell Cycle 12 (2013), 3537–3546.
111. Dou, Z., Xu, C., Donahue, G., Shimi, T., Pan, J.A., Zhu, J., Ivanov, A., Capell, B.C., Drake, A.M., Shah, P.P., Catanzaro, J.M., Ricketts, M.D., Lamark, T., Adam, S.A., Marmorstein, R., Zong, W.X., Johansen, T., Goldman, R.D., Adams, P.D., Berger, S.L., Autophagy mediates degradation of nuclear lamina. Nature 527 (2015), 105–109.
112. Drummond, M.J., Mccarthy, J.J., Sinha, M., Spratt, H.M., Volpi, E., Esser, K.A., Rasmussen, B.B., Aging and microRNA expression in human skeletal muscle: a microarray and bioinformatics analysis. Physiol. Genomics 43 (2011), 595–603.
113. Du, W., Pogoriler, J., Retinoblastoma family genes. Oncogene 25 (2006), 5190–5200.
114. Du, J.M., Johnson, L.M., Jacobsen, S.E., Patel, D.J., DNA methylation pathways and their crosstalk with histone methylation. Nat. Rev. Mol. Cell Biol. 16 (2015), 519–532.
115. El-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K.W., Vogelstein, B., WAF1, a potential mediator of p53 tumor suppression. Cell 75 (1993), 817–825.
116. El-Deiry, W.S., Harper, J.W., O'connor, P.M., Velculescu, V.E., Canman, C.E., Jackman, J., Pietenpol, J.A., Burrell, M., Hill, D.E., Wang, Y., et al. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54 (1994), 1169–1174.
117. Ellinger-Ziegelbauer, H., Kelly, K., Siebenlist, U., Cell cycle arrest and reversion of Ras-induced transformation by a conditionally activated form of mitogen-activated protein kinase kinase kinase 3. Mol. Cell. Biol. 19 (1999), 3857–3868.
118. Elsharawy, A., Keller, A., Flachsbart, F., Wendschlag, A., Jacobs, G., Kefer, N., Brefort, T., Leidinger, P., Backes, C., Meese, E., Schreiber, S., Rosenstiel, P., Franke, A., Nebel, A., Genome-wide miRNA signatures of human longevity. Aging Cell 11 (2012), 607–616.
119. Ertekin, S., Yildirim, O., Dinc, E., Ayaz, L., Fidanci, S.B., Tamer, L., Evaluation of circulating miRNAs in wet age-related macular degeneration. Mol. Vis. 20 (2014), 1057–1066.
120. Fabian, M.R., Sonenberg, N., The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nat. Struct. Mol. Biol. 19 (2012), 586–593.
121. Fang, L., Igarashi, M., Leung, J., Sugrue, M.M., Lee, S.W., Aaronson, S.A., p21Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53. Oncogene 18 (1999), 2789–2797.
122. Farooqi, A.A., Fayyaz, S., Shatynska-Mytsyk, I., Javed, Z., Jabeen, S., Yaylim, I., Gasparri, M.L., Panici, P.B., Is miR-34a a well-equipped swordsman to conquer temple of molecular oncology?. Chem. Biol. Drug Des. 87 (2016), 321–334.
123. Fazzari, M.J., Greally, J.M., Epigenomics: beyond CpG islands. Nat. Rev. Genet. 5 (2004), 446–455.
124. Fedele, M., Fusco, A., HMGA and cancer. Biochim. Biophys. Acta 1799 (2010), 48–54.
125. Feldser, D.M., Greider, C.W., Short telomeres limit tumor progression in vivo by inducing senescence. Cancer Cell 11 (2007), 461–469.
126. Feng, M., Yu, Q., miR-449 regulates CDK-Rb-E2F1 through an auto-regulatory feedback circuit. Cell Cycle 9 (2010), 213–214.
127. Feng, Z., Zhang, C., Wu, R., Hu, W., Tumor suppressor p53 meets microRNAs. J. Mol. Cell Biol. 3 (2011), 44–50.
128. Ferbeyre, G., De Stanchina, E., Querido, E., Baptiste, N., Prives, C., Lowe, S.W., PML is induced by oncogenic ras and promotes premature senescence. Genes Dev. 14 (2000), 2015–2027.
129. Ferbeyre, G., De Stanchina, E., Lin, A.W., Querido, E., Mccurrach, M.E., Hannon, G.J., Lowe, S.W., Oncogenic ras and p53 cooperate to induce cellular senescence. Mol. Cell. Biol. 22 (2002), 3497–3508.
130. Fineberg, S.K., Datta, P., Stein, C.S., Davidson, B.L., MiR-34a represses Numbl in murine neural progenitor cells and antagonizes neuronal differentiation. PLoS One, 7, 2012, e38562.
131. Finkel, T., Deng, C.X., Mostoslavsky, R., Recent progress in the biology and physiology of sirtuins. Nature 460 (2009), 587–591.
132. Franceschi, C., Campisi, J., Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J. Gerontol. A Biol. Sci. Med. Sci. 69:Suppl. 1 (2014), S4–S9.
133. Friedman, D.S., O'colmain, B.J., Munoz, B., Tomany, S.C., Mccarty, C., De Jong, P.T., Nemesure, B., Mitchell, P., Kempen, J., Eye Diseases Prevalence Research, G., Prevalence of age-related macular degeneration in the United States. Arch. Ophthalmol. 122 (2004), 564–572.
134. Friedman, R.C., Farh, K.K., Burge, C.B., Bartel, D.P., Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19 (2009), 92–105.
135. Fumagalli, M., Rosiello, F., Clerici, M., Barozzi, S., Cittaro, D., Kaplunov, J.M., Bucci, G., Dobreva, M., Matti, V., Beausejour, C.M., Herbig, U., Longhese, M.P., Di Fagagna, F.D., Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation. Nat. Cell Biol. 14 (2012), 355–365.
136. Furuta, M., Kozaki, K.I., Tanaka, S., Arii, S., Imoto, I., Inazawa, J., miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 31 (2010), 766–776.
137. Gallardo, E., Navarro, A., Vinolas, N., Marrades, R.M., Diaz, T., Gel, B., Quera, A., Bandres, E., Garcia-Foncillas, J., Ramirez, J., Monzo, M., miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer. Carcinogenesis 30 (2009), 1903–1909.
138. Gaughwin, P.M., Ciesla, M., Lahiri, N., Tabrizi, S.J., Brundin, P., Bjorkqvist, M., Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease. Hum. Mol. Genet. 20 (2011), 2225–2237.
139. Gebert, L.F., Rebhan, M.A., Crivelli, S.E., Denzler, R., Stoffel, M., Hall, J., Miravirsen (SPC3649) can inhibit the biogenesis of miR-122. Nucleic Acids Res. 42 (2014), 609–621.
140. Geyer, R.K., Yu, Z.K., Maki, C.G., The MDM2 RING-finger domain is required to promote p53 nuclear export. Nat. Cell Biol. 2 (2000), 569–573.
141. Giacinti, C., Giordano, A., RB and cell cycle progression. Oncogene 25 (2006), 5220–5227.
142. Gil, J., Bernard, D., Martinez, D., Beach, D., Polycomb CBX7 has a unifying role in cellular lifespan. Nat. Cell Biol. 6 (2004), 67–72.
143. Ginjala, V., Nacerddine, K., Kulkarni, A., Oza, J., Hill, S.J., Yao, M., Citterio, E., Van Lohuizen, M., Ganesan, S., BMI1 is recruited to DNA breaks and contributes to DNA damage-induced H2A ubiquitination and repair. Mol. Cell. Biol. 31 (2011), 1972–1982.
144. Gire, W., Roux, P., Wynford-Thomas, D., Brondello, J.M., Dulic, V., DNA damage checkpoint kinase Chk2 triggers replicative senescence. EMBO J. 23 (2004), 2554–2563.
145. Godlewski, J., Nowicki, M.O., Bronisz, A., Williams, S., Otsuki, A., Nuovo, G., Raychaudhury, A., Newton, H.B., Chiocca, E.A., Lawler, S., Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res. 68 (2008), 9125–9130.
146. Grassmann, F., Schoenberger, P.G., Brandl, C., Schick, T., Hasler, D., Meister, G., Fleckenstein, M., Lindner, M., Helbig, H., Fauser, S., Weber, B.H., A circulating microrna profile is associated with late-stage neovascular age-related macular degeneration. PLoS One, 9, 2014, e107461.
147. Greider, C.W., Blackburn, E.H., Identification of a specific telomere terminal transferase-activity in tetrahymena extracts. Cell 43 (1985), 405–413.
148. Guarino, M., Src signaling in cancer invasion. J. Cell. Physiol. 223 (2010), 14–26.
149. Guil, S., Esteller, M., DNA methylomes, histone codes and miRNAs: tying it all together. Int. J. Biochem. Cell Biol. 41 (2009), 87–95.
150. Guo, X., Keyes, W.M., Papazoglu, C., Zuber, J., Li, W., Lowe, S.W., Vogel, H., Mills, A.A., TAp63 induces senescence and suppresses tumorigenesis in vivo. Nat. Cell Biol. 11 (2009), 1451–1457.
151. Hackl, M., Brunner, S., Fortschegger, K., Schreiner, C., Micutkova, L., Muck, C., Laschober, G.T., Lepperdinger, G., Sampson, N., Berger, P., Herndler-Brandstetter, D., Wieser, M., Kuhnel, H., Strasser, A., Rinnerthaler, M., Breitenbach, M., Mildner, M., Eckhart, L., Tschachler, E., Trost, A., Bauer, J.W., Papak, C., Trajanoski, Z., Scheideler, M., Grillari-Voglauer, R., Grubeck-Loebenstein, B., Jansen-Durr, P., Grillari, J., miR-17, miR-19b, miR-20a, and miR-106a are down-regulated in human aging. Aging Cell 9 (2010), 291–296.
152. Hahn, W.C., Dessain, S.K., Brooks, M.W., King, J.E., Elenbaas, B., Sabatini, D.M., Decaprio, J.A., Weinberg, R.A., Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol. Cell. Biol. 22 (2002), 2111–2123.
153. Hara, E., Smith, R., Parry, D., Tahara, H., Stone, S., Peters, G., Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol. Cell. Biol. 16 (1996), 859–867.
154. Harper, J.W., Adami, G.R., Wei, N., Keyomarsi, K., Elledge, S.J., The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75 (1993), 805–816.
155. Hayflick, L., The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37 (1965), 614–636.
156. Hayflick, L., Moorhead, P.S., The serial cultivation of human diploid cell strains. Exp. Cell Res. 25 (1961), 585–621.
157. He, L., He, X.Y., Lim, L.P., De Stanchina, E., Xuan, Z.Y., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., Jackson, A.L., Linsley, P.S., Chen, C.F., Lowe, S.W., Cleary, M.A., Hannon, G.J., A microRNA component of the p53 tumour suppressor network. Nature, 447, 2007, 1130 U16.
158. Herbig, U., Jobling, W.A., Chen, B.P., Chen, D.J., Sedivy, J.M., Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol. Cell 14 (2004), 501–513.
159. Herbig, U., Ferreira, M., Condel, L., Carey, D., Sedivy, J.M., Cellular senescence in aging primates. Science, 311, 2006, 1257.
160. Hermeking, H., MicroRNAs in the p53 network: micromanagement of tumour suppression. Nat. Rev. Cancer 12 (2012), 613–626.
161. Herranz, D., Serrano, M., Impact of Sirt1 on mammalian aging. Aging (Albany NY) 2 (2010), 315–316.
162. Herranz, N., Gallage, S., Mellone, M., Wuestefeld, T., Klotz, S., Hanley, C.J., Raguz, S., Acosta, J.C., Innes, A.J., Banito, A., Georgilis, A., Montoya, A., Wolter, K., Dharmalingam, G., Faull, P., Carroll, T., Martinez-Barbera, J.P., Cutillas, P., Reisinger, F., Heikenwalder, M., Miller, R.A., Withers, D., Zender, L., Thomas, G.J., Gil, J., mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype. Nat. Cell Biol. 17 (2015), 1205–1217.
163. Hildesheim, J., Bulavin, D.V., Anver, M.R., Alvord, W.G., Hollander, M.C., Vardanian, L., Fornace, A.J., Gadd45a protects against UV irradiation-induced skin tumors, and promotes apoptosis and stress signaling via MAPK and p53. Cancer Res. 62 (2002), 7305–7315.
164. Hoenicke, L., Zender, L., Immune surveillance of senescent cells—biological significance in cancer- and non-cancer pathologies. Carcinogenesis 33 (2012), 1123–1126.
165. Hollstein, M., Sidransky, D., Vogelstein, B., Harris, C.C., P53 mutations in human cancers. Science 253 (1991), 49–53.
166. Honda, R., Yasuda, H., Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase. Oncogene 19 (2000), 1473–1476.
167. Hu, H., Gatti, R.A., MicroRNAs: new players in the DNA damage response. J. Mol. Cell Biol. 3 (2011), 151–158.
168. Hu, Z., Klein, J.D., Mitch, W.E., Zhang, L., Martinez, I., Wang, X.H., MicroRNA-29 induces cellular senescence in aging muscle through multiple signaling pathways. Aging (Albany NY) 6 (2014), 160–175.
169. Huang, L., Luo, J., Cai, Q., Pan, Q., Zeng, H., Guo, Z., Dong, W., Huang, J., Lin, T., MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3. Int. J. Cancer 128 (2011), 1758–1769.
170. Humbert, P.O., Verona, R., Trimarchi, J.M., Rogers, C., Dandapani, S., Lees, J.A., E2f3 is critical for normal cellular proliferation. Genes Dev. 14 (2000), 690–703.
171. Hyman, L., Epidemiology of eye disease in the elderly. Eye (Lond.) 1:Pt. 2 (1987), 330–341.
172. Iliopoulos, D., Malizos, K.N., Oikonomou, P., Tsezou, A., Integrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks. PLoS One, 3, 2008, e3740.
173. Iorio, M.V., Ferracin, M., Liu, C.G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., Menard, S., Palazzo, J.P., Rosenberg, A., Musiani, P., Volinia, S., Nenci, I., Calin, G.A., Querzoli, P., Negrini, M., Croce, C.M., MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 65 (2005), 7065–7070.
174. Itahana, K., Campisi, J., Dimri, G.P., Mechanisms of cellular senescence in human and mouse cells. Biogerontology 5 (2004), 1–10.
175. Ito, T., Yagi, S., Yamakuchi, M., MicroRNA-34a regulation of endothelial senescence. Biochem. Biophys. Res. Commun. 398 (2010), 735–740.
176. Ivanov, A., Pawlikowski, J., Manoharan, I., Van Tuyn, J., Nelson, D.M., Rai, T.S., Shah, P.P., Hewitt, G., Korolchuk, V.I., Passos, J.F., Wu, H., Berger, S.L., Adams, P.D., Lysosome-mediated processing of chromatin in senescence. J. Cell Biol. 202 (2013), 129–143.
177. Ivanovska, I., Ball, A.S., Diaz, R.L., Magnus, J.F., Kibukawa, M., Schelter, J.M., Kobayashi, S.V., Lim, L., Burchard, J., Jackson, A.L., Linsley, P.S., Cleary, M.A., MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol. Cell. Biol. 28 (2008), 2167–2174.
178. Iyer, A., Zurolo, E., Prabowo, A., Fluiter, K., Spliet, W.G., Van Rijen, P.C., Gorter, J.A., Aronica, E., MicroRNA-146a: a key regulator of astrocyte-mediated inflammatory response. PLoS One, 7, 2012, e44789.
179. Jacobs, J.J., Kieboom, K., Marino, S., Depinho, R.A., Van Lohuizen, M., The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397 (1999), 164–168.
180. Janssen, H.L., Reesink, H.W., Zeuzem, S., Lawitz, E., Rodriguez-Torres, M., Chen, A., Davis, C., King, B., Levin, A.A., Hodges, M.R., A randomized, double-blind, placebo (plb) controlled safety and anti-viral proof of concept study of miravirsen (MIR), an oligonucleotide targeting miR-122, in treatment naïve patients with genotype 1 (gt1) chronic HCV infection. Hepatology, 54(4), 2011, 1430A.
181. Jazbutyte, V., Fiedler, J., Kneitz, S., Galuppo, P., Just, A., Holzmann, A., Bauersachs, J., Thum, T., MicroRNA-22 increases senescence and activates cardiac fibroblasts in the aging heart. Age (Dordr.) 35 (2013), 747–762.
182. Jeyapalan, J.C., Ferreira, M., Sedivy, J.M., Herbig, U., Accumulation of senescent cells in mitotic tissue of aging primates. Mech. Ageing Dev. 128 (2007), 36–44.
183. Jia, L.H., Liu, Y.N., Downregulated serum miR-223 servers as biomarker in Alzheimer's disease. Cell Biochem. Funct. 34 (2016), 233–237.
184. Jin, S.Q., Mazzacurati, L., Zhu, X.C., Tong, T., Song, Y.M., Shao, S.J., Petrik, K.L., Rajasekaran, B., Wu, M., Zhan, Q.M., Gadd45a contributes to p53 stabilization in response to DNA damage. Oncogene 22 (2003), 8536–8540.
185. Jin, M., Zhang, T., Liu, C., Badeaux, M.A., Liu, B., Liu, R., Jeter, C., Chen, X., Vlassov, A.V., Tang, D.G., miRNA-128 suppresses prostate cancer by inhibiting BMI-1 to inhibit tumor-initiating cells. Cancer Res. 74 (2014), 4183–4195.
186. Joaquin, M., Watson, R.J., Cell cycle regulation by the B-Myb transcription factor. Cell Mol. Life Sci. 60 (2003), 2389–2401.
187. Johnson, S.M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., Labourier, E., Reinert, K.L., Brown, D., Slack, F.J., RAS is regulated by the let-7 MicroRNA family. Cell 120 (2005), 635–647.
188. Jun, J.I., Lau, L.F., The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat. Cell Biol. 12 (2010), 676–685.
189. Kamijo, T., Van De Kamp, E., Chong, M.J., Zindy, F., Diehl, J.A., Sherr, C.J., Mckinnon, P.J., Loss of the ARF tumor suppressor reverses premature replicative arrest but not radiation hypersensitivity arising from disabled atm function. Cancer Res. 59 (1999), 2464–2469.
190. Karlseder, J., Smogorzewska, A., De Lange, T., Senescence induced by altered telomere state, not telomere loss. Science 295 (2002), 2446–2449.
191. Karube, Y., Tanaka, H., Osada, H., Tomida, S., Tatematsu, Y., Yanagisawa, K., Yatabe, Y., Takamizawa, J., Miyoshi, S., Mitsudomi, T., Takahashi, T., Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci. 96 (2005), 111–115.
192. Kasinski, A.L., Slack, F.J., Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat. Rev. Cancer 11 (2011), 849–864.
193. Keller, A., Backes, C., Haas, J., Leidinger, P., Maetzler, W., Deuschle, C., Berg, D., Ruschil, C., Galata, V., Ruprecht, K., Stahler, C., Wurstle, M., Sickert, D., Gogol, M., Meder, B., Meese, E., Validating Alzheimer's disease micro RNAs using next-generation sequencing. Alzheimers Dement. 12 (2016), 565–576.
194. Kent, O.A., Chivukula, R.R., Mullendore, M., Wentzel, E.A., Feldmann, G., Lee, K.H., Liu, S., Leach, S.D., Maitra, A., Mendell, J.T., Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway. Genes Dev. 24 (2010), 2754–2759.
195. Kim, V.N., Han, J., Siomi, M.C., Biogenesis of small RNAs in animals. Nat. Rev. Mol. Cell Biol. 10 (2009), 126–139.
196. Kim, M.S., Oh, J.E., Kim, Y.R., Park, S.W., Kang, M.R., Kim, S.S., Ahn, C.H., Yoo, N.J., Lee, S.H., Somatic mutations and losses of expression of microRNA regulation-related genes AGO2 and TNRC6A in gastric and colorectal cancers. J. Pathol. 221 (2010), 139–146.
197. Kitadate, A., Ikeda, S., Teshima, K., Ito, M., Toyota, I., Hasunuma, N., Takahashi, N., Miyagaki, T., Sugaya, M., Tagawa, H., MicroRNA-16 mediates the regulation of a senescence-apoptosis switch in cutaneous T-cell and other non-Hodgkin lymphomas. Oncogene 35 (2016), 3692–3704.
198. Koch, C.M., Andrews, R.M., Flicek, P., Dillon, S.C., Karaoz, U., Clelland, G.K., Wilcox, S., Beare, D.M., Fowler, J.C., Couttet, P., James, K.D., Lefebvre, G.C., Bruce, A.W., Dovey, O.M., Ellis, P.D., Dhami, P., Langford, C.F., Weng, Z.P., Birney, E., Carter, N.P., Vetrie, D., Dunham, I., The landscape of histone modifications across 1% of the human genome in five human cell lines. Genome Res. 17 (2007), 691–707.
199. Kondo, H., Kim, H.W., Wang, L., Okada, M., Paul, C., Millard, R.W., Wang, Y., Blockade of senescence-associated microRNA-195 in aged skeletal muscle cells facilitates reprogramming to produce induced pluripotent stem cells. Aging Cell 15 (2016), 56–66.
200. Kortlever, R.M., Higgins, P.J., Bernards, R., Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence. Nat. Cell Biol. 8 (2006), 877–884.
201. Kosar, M., Bartkova, J., Hubackova, S., Hodny, Z., Lukas, J., Bartek, J., Senescence-associated heterochromatin foci are dispensable for cellular senescence, occur in a cell type- and insult-dependent manner and follow expression of p16(ink4a). Cell Cycle 10 (2011), 457–468.
202. Kozaki, K., Imoto, I., Mogi, S., Omura, K., Inazawa, J., Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res. 68 (2008), 2094–2105.
203. Krishnamurthy, J., Torrice, C., Ramsey, M.R., Kovalev, G.I., Al-Regaiey, K., Su, L., Sharpless, N.E., Ink4a/Arf expression is a biomarker of aging. J. Clin. Invest. 114 (2004), 1299–1307.
204. Kruse, J.P., Gu, W., Modes of p53 regulation. Cell 137 (2009), 609–622.
205. Krzeszinski, J.Y., Wei, W., Huynh, H., Jin, Z., Wang, X., Chang, T.C., Xie, X.J., He, L., Mangala, L.S., Lopez-Berestein, G., Sood, A.K., Mendell, J.T., Wan, Y., miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2. Nature 512 (2014), 431–435.
206. Kuilman, T., Michaloglou, C., Vredeveld, L.C., Douma, S., Van Doorn, R., Desmet, C.J., Aarden, L.A., Mooi, W.J., Peeper, D.S., Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133 (2008), 1019–1031.
207. Kuilman, T., Michaloglou, C., Mooi, W.J., Peeper, D.S., The essence of senescence. Genes Dev. 24 (2010), 2463–2479.
208. Kumar, M., Lu, Z., Takwi, A.A., Chen, W., Callander, N.S., Ramos, K.S., Young, K.H., Li, Y., Negative regulation of the tumor suppressor p53 gene by microRNAs. Oncogene 30 (2011), 843–853.
209. Kumar, P., Dezso, Z., Mackenzie, C., Oestreicher, J., Agoulnik, S., Byrne, M., Bernier, F., Yanagimachi, M., Aoshima, K., Oda, Y., Circulating miRNA biomarkers for Alzheimer's disease. PLoS One, 8, 2013, e69807.
210. Kunz, C., Pebler, S., Otte, J., Von Der Ahe, D., Differential regulation of plasminogen activator and inhibitor gene transcription by the tumor suppressor p53. Nucleic Acids Res. 23 (1995), 3710–3717.
211. Kutty, R.K., Nagineni, C.N., Samuel, W., Vijayasarathy, C., Jaworski, C., Duncan, T., Cameron, J.E., Flemington, E.K., Hooks, J.J., Redmond, T.M., Differential regulation of microRNA-146a and microRNA-146b-5p in human retinal pigment epithelial cells by interleukin-1beta, tumor necrosis factor-alpha, and interferon-gamma. Mol. Vis. 19 (2013), 737–750.
212. Laberge, R.M., Sun, Y., Orjalo, A.V., Patil, C.K., Freund, A., Zhou, L., Curran, S.C., Davalos, A.R., Wilson-Edell, K.A., Liu, S., Limbad, C., Demaria, M., Li, P., Hubbard, G.B., Ikeno, Y., Javors, M., Desprez, P.Y., Benz, C.C., Kapahi, P., Nelson, P.S., Campisi, J., MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation. Nat. Cell Biol. 17 (2015), 1049–1061.
213. Lal, A., Kim, H.H., Abdelmohsen, K., Kuwano, Y., Pullmann, R. Jr., Srikantan, S., Subrahmanyam, R., Martindale, J.L., Yang, X., Ahmed, F., Navarro, F., Dykxhoorn, D., Lieberman, J., Gorospe, M., p16(INK4a) translation suppressed by miR-24. PLoS One, 3, 2008, e1864.
214. Lampson, B.L., Pershing, N.L., Prinz, J.A., Lacsina, J.R., Marzluff, W.F., Nicchitta, C.V., Macalpine, D.M., Counter, C.M., Rare codons regulate KRas oncogenesis. Curr. Biol. 23 (2013), 70–75.
215. Lan, F.F., Wang, H., Chen, Y.C., Chan, C.Y., Ng, S.S., Li, K., Xie, D., He, M.L., Lin, M.C., Kung, H.F., Hsa-let-7g inhibits proliferation of hepatocellular carcinoma cells by downregulation of c-Myc and upregulation of p16(INK4A). Int. J. Cancer 128 (2011), 319–331.
216. Langley, E., Pearson, M., Faretta, M., Bauer, U.M., Frye, R.A., Minucci, S., Pelicci, P.G., Kouzarides, T., Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J. 21 (2002), 2383–2396.
217. Lazzerini Denchi, E., Helin, K., E2F1 is crucial for E2F-dependent apoptosis. EMBO Rep. 6 (2005), 661–668.
218. Le, M.T., Teh, C., Shyh-Chang, N., Xie, H., Zhou, B., Korzh, V., Lodish, H.F., Lim, B., MicroRNA-125b is a novel negative regulator of p53. Genes Dev. 23 (2009), 862–876.
219. Lee, Y.S., Dutta, A., The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev. 21 (2007), 1025–1030.
220. Lee, R.C., Feinbaum, R.L., Ambros, V., The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75 (1993), 843–854.
221. Lee, Y., Jeon, K., Lee, J.T., Kim, S., Kim, V.N., MicroRNA maturation: stepwise processing and subcellular localization. EMBO J. 21 (2002), 4663–4670.
222. Lee, Y., Kim, M., Han, J., Yeom, K.H., Lee, S., Baek, S.H., Kim, V.N., MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 23 (2004), 4051–4060.
223. Lee, B.Y., Han, J.A., Im, J.S., Morrone, A., Johung, K., Goodwin, E.C., Kleijer, W.J., Dimaio, D., Hwang, E.S., Senescence-associated beta-galactosidase is lysosomal beta-galactosidase. Aging Cell 5 (2006), 187–195.
224. Lee, S., Jung, J.W., Park, S.B., Roh, K., Lee, S.Y., Kim, J.H., Kang, S.K., Kang, K.S., Histone deacetylase regulates high mobility group A2-targeting microRNAs in human cord blood-derived multipotent stem cell aging. Cell. Mol. Life Sci. 68 (2011), 325–336.
225. Lehmann, U., Hasemeier, B., Christgen, M., Muller, M., Romermann, D., Langer, F., Kreipe, H., Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer. J. Pathol. 214 (2008), 17–24.
226. Lehmann, B.D., Bauer, J.A., Chen, X., Sanders, M.E., Chakravarthy, A.B., Shyr, Y., Pietenpol, J.A., Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J. Clin. Invest. 121 (2011), 2750–2767.
227. Lehmann, S.M., Kruger, C., Park, B., Derkow, K., Rosenberger, K., Baumgart, J., Trimbuch, T., Eom, G., Hinz, M., Kaul, D., Habbel, P., Kalin, R., Franzoni, E., Rybak, A., Nguyen, D., Veh, R., Ninnemann, O., Peters, O., Nitsch, R., Heppner, F.L., Golenbock, D., Schott, E., Ploegh, H.L., Wulczyn, F.G., Lehnardt, S., An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nat. Neurosci. 15 (2012), 827–835.
228. Leidinger, P., Backes, C., Deutscher, S., Schmitt, K., Mueller, S.C., Frese, K., Haas, J., Ruprecht, K., Paul, F., Stahler, C., Lang, C.J., Meder, B., Bartfai, T., Meese, E., Keller, A., A blood based 12-miRNA signature of Alzheimer disease patients. Genome Biol., 14, 2013, R78.
229. Lembo, A., Di Cunto, F., Provero, P., Shortening of 3’UTRs correlates with poor prognosis in breast and lung cancer. PLoS One, 7, 2012, e31129.
230. Li, Y., Tan, W., Neo, T.W., Aung, M.O., Wasser, S., Lim, S.G., Tan, T.M., Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. Cancer Sci. 100 (2009), 1234–1242.
231. Li, N., Bates, D.J., An, J., Terry, D.A., Wang, E., Up-regulation of key microRNAs, and inverse down-regulation of their predicted oxidative phosphorylation target genes, during aging in mouse brain. Neurobiol. Aging 32 (2011), 944–955.
232. Li, X., Khanna, A., Li, N., Wang, E., Circulatory miR34a as an RNAbased, noninvasive biomarker for brain aging. Aging (Albany NY) 3 (2011), 985–1002.
233. Li, M., Fu, W., Wo, L., Shu, X., Liu, F., Li, C., miR-128 and its target genes in tumorigenesis and metastasis. Exp. Cell Res. 319 (2013), 3059–3064.
234. Lin, S., Gregory, R.I., MicroRNA biogenesis pathways in cancer. Nat. Rev. Cancer 15 (2015), 321–333.
235. Lin, A.W., Barradas, M., Stone, J.C., Van Aelst, L., Serrano, M., Lowe, S.W., Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev. 12 (1998), 3008–3019.
236. Lin, H.K., Chen, Z., Wang, G., Nardella, C., Lee, S.W., Chan, C.H., Yang, W.L., Wang, J., Egia, A., Nakayama, K.I., Cordon-Cardo, C., Teruya-Feldstein, J., Pandolfi, P.P., Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence. Nature 464 (2010), 374–379.
237. Lindow, M., Kauppinen, S., Discovering the first microRNA-targeted drug. J. Cell Biol. 199 (2012), 407–412.
238. Liu, Y.N., Lee, W.W., Wang, C.Y., Chao, T.H., Chen, Y., Chen, J.H., Regulatory mechanisms controlling human E-cadherin gene expression. Oncogene 24 (2005), 8277–8290.
239. Liu, M., Lang, N., Qiu, M., Xu, F., Li, Q., Tang, Q., Chen, J., Chen, X., Zhang, S., Liu, Z., Zhou, J., Zhu, Y., Deng, Y., Zheng, Y., Bi, F., miR-137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells. Int. J. Cancer 128 (2011), 1269–1279.
240. Liu, N., Landreh, M., Cao, K., Abe, M., Hendriks, G.J., Kennerdell, J.R., Zhu, Y., Wang, L.S., Bonini, N.M., The microRNA miR-34 modulates ageing and neurodegeneration in Drosophila. Nature 482 (2012), 519–523.
241. Liu, C.H., Sun, Y., Li, J., Gong, Y., Tian, K.T., Evans, L.P., Morss, P.C., Fredrick, T.W., Saba, N.J., Chen, J., Endothelial microRNA-150 is an intrinsic suppressor of pathologic ocular neovascularization. Proc. Natl. Acad. Sci. U.S.A. 112 (2015), 12163–12168.
242. Liu, Y., Li, X., Zhu, S., Zhang, J.G., Yang, M., Qin, Q., Deng, S.C., Wang, B., Tian, K., Liu, L., Niu, Y., Wang, C.Y., Zhao, G., Ectopic expression of miR-494 inhibited the proliferation, invasion and chemoresistance of pancreatic cancer by regulating SIRT1 and c-Myc. Gene Ther. 22 (2015), 729–738.
243. Lowe, S.W., Sherr, C.J., Tumor suppression by Ink4a-Arf: progress and puzzles. Curr. Opin. Genet. Dev. 13 (2003), 77–83.
244. Lowe, S.W., Cepero, E., Evan, G., Intrinsic tumour suppression. Nature 432 (2004), 307–315.
245. Lu, J., Getz, G., Miska, E.A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B.L., Mak, R.H., Ferrando, A.A., Downing, J.R., Jacks, T., Horvitz, H.R., Golub, T.R., MicroRNA expression profiles classify human cancers. Nature 435 (2005), 834–838.
246. Lukiw, W.J., Andreeva, T.V., Grigorenko, A.P., Rogaev, E.I., Studying micro RNA function and dysfunction in Alzheimer's disease. Front. Genet., 3, 2012, 327.
247. Luo, J., Nikolaev, A.Y., Imai, S., Chen, D., Su, F., Shiloh, A., Guarente, L., Gu, W., Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107 (2001), 137–148.
248. Luo, W., Li, G., Yi, Z., Nie, Q., Zhang, X., E2F1-miR-20a-5p/20b-5p auto-regulatory feedback loop involved in myoblast proliferation and differentiation. Sci. Rep., 6, 2016, 27904.
249. Maehara, K., Yamakoshi, K., Ohtani, N., Kubo, Y., Takahashi, A., Arase, S., Jones, N., Hara, E., Reduction of total E2F/DP activity induces senescence-like cell cycle arrest in cancer cells lacking functional pRB and p53. J. Cell Biol. 168 (2005), 553–560.
250. Maier, B., Gluba, W., Bernier, B., Turner, T., Mohammad, K., Guise, T., Sutherland, A., Thorner, M., Scrable, H., Modulation of mammalian life span by the short isoform of p53. Genes Dev. 18 (2004), 306–319.
251. Mallette, F.A., Ferbeyre, G., The DNA damage signaling pathway connects oncogenic stress to cellular senescence. Cell Cycle 6 (2007), 1831–1836.
252. Mallette, F.A., Richard, S., JMJD2A promotes cellular transformation by blocking cellular senescence through transcriptional repression of the tumor suppressor CHD5. Cell Rep. 2 (2012), 1233–1243.
253. Mallette, F.A., Gaumont-Leclerc, M.F., Ferbeyre, G., The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence. Genes Dev. 21 (2007), 43–48.
254. Mallette, F.A., Gaumont-Leclerc, M.F., Huot, G., Ferbeyre, G., Myc down-regulation as a mechanism to activate the Rb pathway in STAT5A-induced senescence. J. Biol. Chem. 282 (2007), 34938–34944.
255. Mallette, F.A., Moiseeva, O., Calabrese, V., Mao, B., Gaumont-Leclerc, M.F., Ferbeyre, G., Transcriptome analysis and tumor suppressor requirements of STAT5-induced senescence. Ann. N. Y. Acad. Sci. 1197 (2010), 142–151.
256. Mandke, P., Wyatt, N., Fraser, J., Bates, B., Berberich, S.J., Markey, M.P., MicroRNA-34a modulates MDM4 expression via a target site in the open reading frame. PLoS One, 7, 2012, e42034.
257. Marasa, B.S., Srikantan, S., Masuda, K., Abdelmohsen, K., Kuwano, Y., Yang, X., Martindale, J.L., Rinker-Schaeffer, C.W., Gorospe, M., Increased MKK4 abundance with replicative senescence is linked to the joint reduction of multiple microRNAs. Sci. Signal., 2, 2009, ra69.
258. Marasa, B.S., Srikantan, S., Martindale, J.L., Kim, M.M., Lee, E.K., Gorospe, M., Abdelmohsen, K., MicroRNA profiling in human diploid fibroblasts uncovers miR-519 role in replicative senescence. Aging (Albany NY) 2 (2010), 333–343.
259. Markey, M., Berberich, S.J., Full-length hdmX transcripts decrease following genotoxic stress. Oncogene 27 (2008), 6657–6666.
260. Markowski, D.N., Helmke, B.M., Belge, G., Nimzyk, R., Bartnitzke, S., Deichert, U., Bullerdiek, J., HMGA2 and p14Arf: major roles in cellular senescence of fibroids and therapeutic implications. Anticancer Res. 31 (2011), 753–761.
261. Martinez, I., Cazalla, D., Almstead, L.L., Steitz, J.A., DiMaio, D., miR-29 and miR-30 regulate B-Myb expression during cellular senescence. Proc. Natl. Acad. Sci. U.S.A. 108 (2011), 522–527.
262. Matheu, A., Maraver, A., Serrano, M., The Arf/p53 pathway in cancer and aging. Cancer Res. 68 (2008), 6031–6034.
263. Matsumura, T., Zerrudo, Z., Hayflick, L., Senescent human diploid cells in culture: survival, DNA synthesis and morphology. J. Gerontol. 34 (1979), 328–334.
264. Mayr, C., Bartel, D.P., Widespread shortening of 3’ UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 138 (2009), 673–684.
265. Mayr, C., Hemann, M.T., Bartel, D.P., Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 315 (2007), 1576–1579.
266. Melo, S.A., Ropero, S., Moutinho, C., Aaltonen, L.A., Yamamoto, H., Calin, G.A., Rossi, S., Fernandez, A.F., Carneiro, F., Oliveira, C., Ferreira, B., Liu, C.G., Villanueva, A., Capella, G., Schwartz, S. Jr., Shiekhattar, R., Esteller, M., A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat. Genet. 41 (2009), 365–370.
267. Menard, C., Rezende, F.A., Miloudi, K., Wilson, A., Tetreault, N., Hardy, P., Sangiovanni, J.P., De Guire, V., Sapieha, P., MicroRNA signatures in vitreous humour and plasma of patients with exudative AMD. Oncotarget 7 (2016), 19171–19184.
268. Menghini, R., Casagrande, V., Cardellini, M., Martelli, E., Terrinoni, A., Amati, F., Vasa-Nicotera, M., Ippoliti, A., Novelli, G., Melino, G., Lauro, R., Federici, M., MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1. Circulation 120 (2009), 1524–1532.
269. Metias, S.M., Lianidou, E., Yousef, G.M., MicroRNAs in clinical oncology: at the crossroads between promises and problems. J. Clin. Pathol. 62 (2009), 771–776.
270. Michaloglou, C., Vredeveld, L.C., Soengas, M.S., Denoyelle, C., Kuilman, T., Van Der Horst, C.M., Majoor, D.M., Shay, J.W., Mooi, W.J., Peeper, D.S., BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436 (2005), 720–724.
271. Migliorini, D., Danovi, D., Colombo, E., Carbone, R., Pelicci, P.G., Marine, J.C., Hdmx recruitment into the nucleus by Hdm2 is essential for its ability to regulate p53 stability and transactivation. J. Biol. Chem. 277 (2002), 7318–7323.
272. Miller, K.R., Kelley, K., Tuttle, R., Berberich, S.J., HdmX overexpression inhibits oncogene induced cellular senescence. Cell Cycle 9 (2010), 3376–3382.
273. Minamino, T., Komuro, I., Vascular cell senescence: contribution to atherosclerosis. Circ. Res. 100 (2007), 15–26.
274. Miranda, K.C., Huynh, T., Tay, Y., Ang, Y.S., Tam, W.L., Thomson, A.M., Lim, B., Rigoutsos, I., A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 126 (2006), 1203–1217.
275. Mitchell, P.S., Parkin, R.K., Kroh, E.M., Fritz, B.R., Wyman, S.K., Pogosova-Agadjanyan, E.L., Peterson, A., Noteboom, J., O'briant, K.C., Allen, A., Lin, D.W., Urban, N., Drescher, C.W., Knudsen, B.S., Stirewalt, D.L., Gentleman, R., Vessella, R.L., Nelson, P.S., Martin, D.B., Tewari, M., Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U.S.A. 105 (2008), 10513–10518.
276. Miyaki, S., Asahara, H., Macro view of microRNA function in osteoarthritis. Nat. Rev. Rheumatol. 8 (2012), 543–552.
277. Miyaki, S., Nakasa, T., Otsuki, S., Grogan, S.P., Higashiyama, R., Inoue, A., Kato, Y., Sato, T., Lotz, M.K., Asahara, H., MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses. Arthritis Rheum. 60 (2009), 2723–2730.
278. Miyaki, S., Sato, T., Inoue, A., Otsuki, S., Ito, Y., Yokoyama, S., Kato, Y., Takemoto, F., Nakasa, T., Yamashita, S., Takada, S., Lotz, M.K., Ueno-Kudo, H., Asahara, H., MicroRNA-140 plays dual roles in both cartilage development and homeostasis. Genes Dev. 24 (2010), 1173–1185.
279. Moiseeva, O., Mallette, F.A., Mukhopadhyay, U.K., Moores, A., Ferbeyre, G., DNA damage signaling and p53-dependent senescence after prolonged beta-interferon stimulation. Mol. Biol. Cell 17 (2006), 1583–1592.
280. Moiseeva, O., Deschenes-Simard, X., St-Germain, E., Igelmann, S., Huot, G., Cadar, A.E., Bourdeau, V., Pollak, M.N., Ferbeyre, G., Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK/NF-kappaB activation. Aging Cell 12 (2013), 489–498.
281. Molnar, A., Theodoras, A.M., Zon, L.I., Kyriakis, J.M., Cdc42Hs, but not rad, inhibits serum-stimulated cell cycle progression at G(1)/S through a mechanism requiring p38/RK. J. Biol. Chem. 272 (1997), 13229–13235.
282. Moyer, A.W., Wallace, R., Cox, H.R., Limited growth period of human lung cell lines transformed by simian virus 40. J. Natl. Cancer Inst. 33 (1964), 227–236.
283. Muller, M., Jakel, L., Bruinsma, I.B., Claassen, J.A., Kuiperij, H.B., Verbeek, M.M., MicroRNA-29a is a candidate biomarker for Alzheimer's disease in cell-free cerebrospinal fluid. Mol. Neurobiol. 53 (2016), 2894–2899.
284. Munker, R., Calin, G.A., MicroRNA profiling in cancer. Clin. Sci. (Lond.) 121 (2011), 141–158.
285. Nahid, M.A., Satoh, M., Chan, E.K., MicroRNA in TLR signaling and endotoxin tolerance. Cell. Mol. Immunol. 8 (2011), 388–403.
286. Nakamura, Y., He, X., Kato, H., Wakitani, S., Kobayashi, T., Watanabe, S., Iida, A., Tahara, H., Warman, M.L., Watanapokasin, R., Postlethwait, J.H., Sox9 is upstream of microRNA-140 in cartilage. Appl. Biochem. Biotechnol. 166 (2012), 64–71.
287. Nakazawa, Y., Kamijo, T., Koike, K., Noda, T., ARF tumor suppressor induces mitochondria-dependent apoptosis by modulation of mitochondrial Bcl-2 family proteins. J. Biol. Chem. 278 (2003), 27888–27895.
288. Narita, M., Nunez, S., Heard, E., Lin, A.W., Hearn, S.A., Spector, D.L., Hannon, G.J., Lowe, S.W., Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113 (2003), 703–716.
289. Narita, M., Krizhanovsky, V., Nunez, S., Chicas, A., Hearn, S.A., Myers, M.P., Lowe, S.W., A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation. Cell 126 (2006), 503–514.
290. Narita, M., Young, A.R., Arakawa, S., Samarajiwa, S.A., Nakashima, T., Yoshida, S., Hong, S., Berry, L.S., Reichelt, S., Ferreira, M., Tavare, S., Inoki, K., Shimizu, S., Narita, M., Spatial coupling of mTOR and autophagy augments secretory phenotypes. Science 332 (2011), 966–970.
291. Navarro, F., Lieberman, J., miR-34 and p53: new insights into a complex functional relationship. PLoS One, 10, 2015, e0132767.
292. Neault, M., Mallette, F.A., Richard, S., miR-137 modulates a tumor suppressor network-inducing senescence in pancreatic cancer cells. Cell Rep. 14 (2016), 1966–1978.
293. Newbold, R.F., Overell, R.W., Fibroblast immortality is a prerequisite for transformation by Ej c-Ha-ras oncogene. Nature 304 (1983), 648–651.
294. Newbold, R.F., Overell, R.W., Connell, J.R., Induction of immortality is an early event in malignant transformation of mammalian-cells by carcinogens. Nature 299 (1982), 633–635.
295. Nielsen, S.J., Schneider, R., Bauer, U.M., Bannister, A.J., Morrison, A., O'carroll, D., Firestein, R., Cleary, M., Jenuwein, T., Herrera, R.E., Kouzarides, T., Rb targets histone H3 methylation and HP1 to promoters. Nature 412 (2001), 561–565.
296. Nishino, J., Kim, I., Chada, K., Morrison, S.J., Hmga2 promotes neural stem cell self-renewal in young but not old mice by reducing p16Ink4a and p19Arf expression. Cell 135 (2008), 227–239.
297. Niwa, R., Zhou, F., Li, C., Slack, F.J., The expression of the Alzheimer's amyloid precursor protein-like gene is regulated by developmental timing microRNAs and their targets in Caenorhabditis elegans. Dev. Biol. 315 (2008), 418–425.
298. Noguchi, S., Mori, T., Otsuka, Y., Yamada, N., Yasui, Y., Iwasaki, J., Kumazaki, M., Maruo, K., Akao, Y., Anti-oncogenic microRNA-203 induces senescence by targeting E2F3 protein in human melanoma cells. J. Biol. Chem. 287 (2012), 11769–11777.
299. Noonan, E.J., Place, R.F., Basak, S., Pookot, D., Li, L.C., miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells. Oncotarget 1 (2010), 349–358.
300. Noren Hooten, N., Abdelmohsen, K., Gorospe, M., Ejiogu, N., Zonderman, A.B., Evans, M.K., microRNA expression patterns reveal differential expression of target genes with age. PLoS One, 5, 2010, e10724.
301. O'donnell, K.A., Wentzel, E.A., Zeller, K.I., Dang, C.V., Mendell, J.T., c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435 (2005), 839–843.
302. Ofir, M., Hacohen, D., Ginsberg, D., MiR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E. Mol. Cancer Res. 9 (2011), 440–447.
303. Okada, N., Lin, C.P., Ribeiro, M.C., Biton, A., Lai, G., He, X., Bu, P., Vogel, H., Jablons, D.M., Keller, A.C., Wilkinson, J.E., He, B., Speed, T.P., He, L., A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression. Genes Dev. 28 (2014), 438–450.
304. Okada, M., Kim, H.W., Matsu-Ura, K., Wang, Y.G., Xu, M., Ashraf, M., Abrogation of age-induced MicroRNA-195 rejuvenates the senescent mesenchymal stem cells by reactivating telomerase. Stem Cells 34 (2016), 148–159.
305. Okano, M., Bell, D.W., Haber, D.A., Li, E., DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99 (1999), 247–257.
306. Olivier, M., Hollstein, M., Hainaut, P., TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb. Perspect. Biol., 2, 2010, a001008.
307. Olivieri, F., Lazzarini, R., Recchioni, R., Marcheselli, F., Rippo, M.R., Di Nuzzo, S., Albertini, M.C., Graciotti, L., Babini, L., Mariotti, S., Spada, G., Abbatecola, A.M., Antonicelli, R., Franceschi, C., Procopio, A.D., MiR-146a as marker of senescence-associated pro-inflammatory status in cells involved in vascular remodelling. Age (Dordr.) 35 (2013), 1157–1172.
308. O'loghlen, A., Brookes, S., Martin, N., Rapisarda, V., Peters, G., Gil, J., CBX7 and miR-9 are part of an autoregulatory loop controlling p16(INK) (4a). Aging Cell 14 (2015), 1113–1121.
309. Olovnikov, A.M., Telomeres, telomerase, and aging: origin of the theory. Exp. Gerontol. 31 (1996), 443–448.
310. Otterson, G.A., Kratzke, R.A., Coxon, A., Kim, Y.W., Kaye, F.J., Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene 9 (1994), 3375–3378.
311. Overhoff, M.G., Garbe, J.C., Koh, J., Stampfer, M.R., Beach, D.H., Bishop, C.L., Cellular senescence mediated by p16INK4A-coupled miRNA pathways. Nucleic Acids Res. 42 (2014), 1606–1618.
312. Palmero, I., Pantoja, C., Serrano, M., p19ARF links the tumour suppressor p53 to Ras. Nature 395 (1998), 125–126.
313. Pampalakis, G., Diamandis, E.P., Katsaros, D., Sotiropoulou, G., Down-regulation of dicer expression in ovarian cancer tissues. Clin. Biochem. 43 (2010), 324–327.
314. Pantoja, C., Serrano, M., Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras. Oncogene 18 (1999), 4974–4982.
315. Papadopoulou, A.S., Serneels, L., Achsel, T., Mandemakers, W., Callaerts-Vegh, Z., Dooley, J., Lau, P., Ayoubi, T., Radaelli, E., Spinazzi, M., Neumann, M., Hebert, S.S., Silahtaroglu, A., Liston, A., D'hooge, R., Glatzel, M., De Strooper, B., Deficiency of the miR-29a/b-1 cluster leads to ataxic features and cerebellar alterations in mice. Neurobiol. Dis. 73 (2015), 275–288.
316. Pearson, M., Carbone, R., Sebastiani, C., Cioce, M., Fagioli, M., Saito, S., Higashimoto, Y., Appella, E., Minucci, S., Pandolfi, P.P., Pelicci, P.G., PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 406 (2000), 207–210.
317. Pesole, G., Mignone, F., Gissi, C., Grillo, G., Licciulli, F., Liuni, S., Structural and functional features of eukaryotic mRNA untranslated regions. Gene 276 (2001), 73–81.
318. Petretto, E., Sarwar, R., Grieve, I., Lu, H., Kumaran, M.K., Muckett, P.J., Mangion, J., Schroen, B., Benson, M., Punjabi, P.P., Prasad, S.K., Pennell, D.J., Kiesewetter, C., Tasheva, E.S., Corpuz, L.M., Webb, M.D., Conrad, G.W., Kurtz, T.W., Kren, V., Fischer, J., Hubner, N., Pinto, Y.M., Pravenec, M., Aitman, T.J., Cook, S.A., Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass. Nat. Genet. 40 (2008), 546–552.
319. Petrocca, F., Visone, R., Onelli, M.R., Shah, M.H., Nicoloso, M.S., De Martino, I., Iliopoulos, D., Pilozzi, E., Liu, C.G., Negrini, M., Cavazzini, L., Volinia, S., Alder, H., Ruco, L.P., Baldassarre, G., Croce, C.M., Vecchione, A., E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 13 (2008), 272–286.
320. Pichiorri, F., Suh, S.S., Rocci, A., De Luca, L., Taccioli, C., Santhanam, R., Zhou, W., Benson, D.M. Jr., Hofmainster, C., Alder, H., Garofalo, M., Di Leva, G., Volinia, S., Lin, H.J., Perrotti, D., Kuehl, M., Aqeilan, R.I., Palumbo, A., Croce, C.M., Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development. Cancer Cell 18 (2010), 367–381.
321. Pierce, A.M., Gimenez-Conti, I.B., Schneider-Broussard, R., Martinez, L.A., Conti, C.J., Johnson, D.G., Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53. Proc. Natl. Acad. Sci. U.S.A. 95 (1998), 8858–8863.
322. Pierson, J., Hostager, B., Fan, R., Vibhakar, R., Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma. J. Neurooncol 90 (2008), 1–7.
323. Poliseno, L., Pitto, L., Simili, M., Mariani, L., Riccardi, L., Ciucci, A., Rizzo, M., Evangelista, M., Mercatanti, A., Pandolfi, P.P., Rainaldi, G., The proto-oncogene LRF is under post-transcriptional control of MiR-20a: implications for senescence. PLoS One, 3, 2008, e2542.
324. Puyol, M., Martin, A., Dubus, P., Mulero, F., Pizcueta, P., Khan, G., Guerra, C., Santamaria, D., Barbacid, M., A synthetic lethal interaction between K-Ras oncogenes and Cdk4 unveils a therapeutic strategy for non-small cell lung carcinoma. Cancer Cell 18 (2010), 63–73.
325. Quelle, D.E., Zindy, F., Ashmun, R.A., Sherr, C.J., Alternative reading frames of the Ink4a tumor-suppressor gene encode 2 unrelated proteins capable of inducing cell-cycle arrest. Cell 83 (1995), 993–1000.
326. Rabinowits, G., Gercel-Taylor, C., Day, J.M., Taylor, D.D., Kloecker, G.H., Exosomal microRNA: a diagnostic marker for lung cancer. Clin. Lung Cancer 10 (2009), 42–46.
327. Ramalinga, M., Roy, A., Srivastava, A., Bhattarai, A., Harish, V., Suy, S., Collins, S., Kumar, D., MicroRNA-212 negatively regulates starvation induced autophagy in prostate cancer cells by inhibiting SIRT1 and is a modulator of angiogenesis and cellular senescence. Oncotarget 6 (2015), 34446–34457.
328. Raman, V., Martensen, S.A., Reisman, D., Evron, E., Odenwald, W.F., Jaffee, E., Marks, J., Sukumar, S., Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature 405 (2000), 974–978.
329. Rane, S.G., Cosenza, S.C., Mettus, R.V., Reddy, E.P., Germ line transmission of the Cdk4(R24C) mutation facilitates tumorigenesis and escape from cellular senescence. Mol. Cell. Biol. 22 (2002), 644–656.
330. Raver-Shapira, N., Marciano, E., Meiri, E., Spector, Y., Rosenfeld, N., Moskovits, N., Bentwich, Z., Oren, M., Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol. Cell 26 (2007), 731–743.
331. Rayman, J.B., Takahashi, Y., Indjeian, V.B., Dannenberg, J.H., Catchpole, S., Watson, R.J., Te Riele, H., Dynlacht, B.D., E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex. Genes Dev. 16 (2002), 933–947.
332. Reimann, M., Lee, S., Loddenkemper, C., Dorr, J.R., Tabor, V., Aichele, P., Stein, H., Dorken, B., Jenuwein, T., Schmitt, C.A., Tumor stroma-derived TGF-beta limits myc-driven lymphomagenesis via Suv39h1-dependent senescence. Cancer Cell 17 (2010), 262–272.
333. Reinhart, B.J., Slack, F.J., Basson, M., Pasquinelli, A.E., Bettinger, J.C., Rougvie, A.E., Horvitz, H.R., Ruvkun, G., The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403 (2000), 901–906.
334. Ren, X.S., Yin, M.H., Zhang, X., Wang, Z., Feng, S.P., Wang, G.X., Luo, Y.J., Liang, P.Z., Yang, X.Q., He, J.X., Zhang, B.L., Tumor-suppressive microRNA-449a induces growth arrest and senescence by targeting E2F3 in human lung cancer cells. Cancer Lett. 344 (2014), 195–203.
335. Riley, T., Sontag, E., Chen, P., Levine, A., Transcriptional control of human p53-regulated genes. Nat. Rev. Mol. Cell Biol. 9 (2008), 402–412.
336. Rivetti Di Val Cervo, P., Lena, A.M., Nicoloso, M., Rossi, S., Mancini, M., Zhou, H., Saintigny, G., Dellambra, E., Odorisio, T., Mahe, C., Calin, G.A., Candi, E., Melino, G., p63-microRNA feedback in keratinocyte senescence. Proc. Natl. Acad. Sci. U.S.A. 109 (2012), 1133–1138.
337. Robertson, K.D., DNA methylation and human disease. Nat. Rev. Genet. 6 (2005), 597–610.
338. Rodier, F., Campisi, J., Four faces of cellular senescence. J. Cell Biol. 192 (2011), 547–556.
339. Rodriguez, M.S., Desterro, J.M., Lain, S., Lane, D.P., Hay, R.T., Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation. Mol. Cell. Biol. 20 (2000), 8458–8467.
340. Rodriguez, A., Griffiths-Jones, S., Ashurst, J.L., Bradley, A., Identification of mammalian microRNA host genes and transcription units. Genome Res. 14 (2004), 1902–1910.
341. Roman-Gomez, J., Agirre, X., Jimenez-Velasco, A., Arqueros, V., Vilas-Zornoza, A., Rodriguez-Otero, P., Martin-Subero, I., Garate, L., Cordeu, L., San Jose-Eneriz, E., Martin, V., Castillejo, J.A., Bandres, E., Calasanz, M.J., Siebert, R., Heiniger, A., Torres, A., Prosper, F., Epigenetic regulation of microRNAs in acute lymphoblastic leukemia. J. Clin. Oncol. 27 (2009), 1316–1322.
342. Romero-Cordoba, S.L., Salido-Guadarrama, I., Rodriguez-Dorantes, M., Hidalgo-Miranda, A., miRNA biogenesis: biological impact in the development of cancer. Cancer Biol. Ther. 15 (2014), 1444–1455.
343. Roshan, R., Shridhar, S., Sarangdhar, M.A., Banik, A., Chawla, M., Garg, M., Singh, V.P., Pillai, B., Brain-specific knockdown of miR-29 results in neuronal cell death and ataxia in mice. RNA 20 (2014), 1287–1297.
344. Rowland, B.D., Bernards, R., Peeper, D.S., The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat. Cell Biol. 7 (2005), 1074–1082.
345. Rupaimoole, R., Slack, F.J., MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat. Rev. Drug Discov. 16 (2017), 203–222.
346. Russo, A.A., Tong, L., Lee, J.O., Jeffrey, P.D., Pavletich, N.P., Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a. Nature 395 (1998), 237–243.
347. Sager, R., Tanaka, K., Lau, C.C., Ebina, Y., Anisowicz, A., Resistance of human cells to tumorigenesis induced by cloned transforming genes. Proc. Natl. Acad. Sci. U.S.A. 80 (1983), 7601–7605.
348. Salama, R., Sadaie, M., Hoare, M., Narita, M., Cellular senescence and its effector programs. Genes Dev. 28 (2014), 99–114.
349. Sarkar, S., Jun, S., Rellick, S., Quintana, D.D., Cavendish, J.Z., Simpkins, J.W., Expression of microRNA-34a in Alzheimer's disease brain targets genes linked to synaptic plasticity, energy metabolism, and resting state network activity. Brain Res. 1646 (2016), 139–151.
350. Sarkisian, C.J., Keister, B.A., Stairs, D.B., Boxer, R.B., Moody, S.E., Chodosh, L.A., Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis. Nat. Cell Biol. 9 (2007), 493–505.
351. Sasaki, M., Kumazaki, T., Takano, H., Nishiyama, M., Mitsui, Y., Senescent cells are resistant to death despite low Bcl-2 level. Mech. Ageing Dev. 122 (2001), 1695–1706.
352. Satoh, A., Brace, C.S., Rensing, N., Cliften, P., Wozniak, D.F., Herzog, E.D., Yamada, K.A., Imai, S., Sirt1 extends life span and delays aging in mice through the regulation of Nk2 homeobox 1 in the DMH and LH. Cell Metab. 18 (2013), 416–430.
353. Schipper, H.M., Maes, O.C., Chertkow, H.M., Wang, E., MicroRNA expression in Alzheimer blood mononuclear cells. Gene Regul. Syst. Biol. 1 (2007), 263–274.
354. Seger, Y.R., Garcia-Cao, M., Piccinin, S., Cunsolo, C.L., Doglioni, C., Blasco, M.A., Hannon, G.J., Maestro, R., Transformation of normal human cells in the absence of telomerase activation. Cancer Cell 2 (2002), 401–413.
355. Senoo, M., Pinto, F., Crum, C.P., Mckeon, F., p63 Is essential for the proliferative potential of stem cells in stratified epithelia. Cell 129 (2007), 523–536.
356. Serrano, M., Lee, H., Chin, L., Cordon-Cardo, C., Beach, D., Depinho, R.A., Role of the INK4a locus in tumor suppression and cell mortality. Cell 85 (1996), 27–37.
357. Serrano, M., Lin, A.W., Mccurrach, M.E., Beach, D., Lowe, S.W., Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88 (1997), 593–602.
358. Shapiro, G.I., Edwards, C.D., Kobzik, L., Godleski, J., Richards, W., Sugarbaker, D.J., Rollins, B.J., Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines. Cancer Res. 55 (1995), 505–509.
359. Shay, J.W., Bacchetti, S., A survey of telomerase activity in human cancer. Eur. J. Cancer 33 (1997), 787–791.
360. Shay, J.W., Wright, W.E., Hayflick, his limit, and cellular ageing. Nat. Rev. Mol. Cell Biol. 1 (2000), 72–76.
361. Shen, J., Yang, X., Xie, B., Chen, Y., Swaim, M., Hackett, S.F., Campochiaro, P.A., MicroRNAs regulate ocular neovascularization. Mol. Ther. 16 (2008), 1208–1216.
362. Shi, X., Tian, B., Liu, L., Gao, Y., Ma, C., Mwichie, N., Ma, W., Han, L., Huang, B., Lu, J., Zhang, Y., Rb protein is essential to the senescence-associated heterochromatic foci formation induced by HMGA2 in primary WI38 cells. J. Genet. Genomics 40 (2013), 391–398.
363. Shieh, S.Y., Ikeda, M., Taya, Y., Prives, C., DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91 (1997), 325–334.
364. Shirodkar, S., Ewen, M., Decaprio, J.A., Morgan, J., Livingston, D.M., Chittenden, T., The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell 68 (1992), 157–166.
365. Shvarts, A., Steegenga, W.T., Riteco, N., Van Laar, T., Dekker, P., Bazuine, M., Van Ham, R.C., Van Der Houven Van Oordt, W., Hateboer, G., Van Der Eb, A.J., Jochemsen, A.G., MDMX: a novel p53-binding protein with some functional properties of MDM2. EMBO J. 15 (1996), 5349–5357.
366. Siebig, S., Rockmann, F., Sabel, K., Zuber-Jerger, I., Dierkes, C., Brunnler, T., Wrede, C.E., Continuous non-invasive arterial pressure technique improves patient monitoring during interventional endoscopy. Int. J. Med. Sci. 6 (2009), 37–42.
367. Smith, J., Tho, L.M., Xu, N., Gillespie, D.A., The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Adv. Cancer Res. 108 (2010), 73–112.
368. Song, R., Walentek, P., Sponer, N., Klimke, A., Lee, J.S., Dixon, G., Harland, R., Wan, Y., Lishko, P., Lize, M., Kessel, M., He, L., miR-34/449 miRNAs are required for motile ciliogenesis by repressing cp110. Nature 510 (2014), 115–120.
369. Soriano-Arroquia, A., House, L., Tregilgas, L., Canty-Laird, E., Goljanek-Whysall, K., The functional consequences of age-related changes in microRNA expression in skeletal muscle. Biogerontology 17 (2016), 641–654.
370. Soto-Reyes, E., Recillas-Targa, F., Epigenetic regulation of the human p53 gene promoter by the CTCF transcription factor in transformed cell lines. Oncogene 29 (2010), 2217–2227.
371. Stevens, C., La Thangue, N.B., E2F and cell cycle control: a double-edged sword. Arch. Biochem. Biophys. 412 (2003), 157–169.
372. Stevenson, M., Volsky, D.J., Activated v-myc and v-ras oncogenes do not transform normal human lymphocytes. Mol. Cell. Biol. 6 (1986), 3410–3417.
373. Sun, F., Fu, H., Liu, Q., Tie, Y., Zhu, J., Xing, R., Sun, Z., Zheng, X., Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest. FEBS Lett. 582 (2008), 1564–1568.
374. Suzuki, H.I., Yamagata, K., Sugimoto, K., Iwamoto, T., Kato, S., Miyazono, K., Modulation of microRNA processing by p53. Nature 460 (2009), 529–533.
375. Sylvestre, Y., De Guire, V., Querido, E., Mukhopadhyay, U.K., Bourdeau, V., Major, F., Ferbeyre, G., Chartrand, P., An E2F/miR-20a autoregulatory feedback loop. J. Biol. Chem. 282 (2007), 2135–2143.
376. Szemraj, M., Bielecka-Kowalska, A., Oszajca, K., Krajewska, M., Gos, R., Jurowski, P., Kowalski, M., Szemraj, J., Serum microRNAs as potential biomarkers of AMD. Med. Sci. Monit. 21 (2015), 2734–2742.
377. Taganov, K.D., Boldin, M.P., Chang, K.J., Baltimore, D., NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. U.S.A. 103 (2006), 12481–12486.
378. Takamizawa, J., Konishi, H., Yanagisawa, K., Tomida, S., Osada, H., Endoh, H., Harano, T., Yatabe, Y., Nagino, M., Nimura, Y., Mitsudomi, T., Takahashi, T., Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 64 (2004), 3753–3756.
379. Talluri, S., Isaac, C.E., Ahmad, M., Henley, S.A., Francis, S.M., Martens, A.L., Bremner, R., Dick, F.A., A G1 checkpoint mediated by the retinoblastoma protein that is dispensable in terminal differentiation but essential for senescence. Mol. Cell. Biol. 30 (2010), 948–960.
380. Tanaka, H., Fujii, Y., Hirabayashi, H., Miyoshi, S., Sakaguchi, M., Yoon, H.E., Matsuda, H., Disruption of the RB pathway and cell-proliferative activity in non-small-cell lung cancers. Int. J. Cancer 79 (1998), 111–115.
381. Tarasov, V., Jung, P., Verdoodt, B., Lodygin, D., Epanchintsev, A., Menssen, A., Meister, G., Hermeking, H., Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 6 (2007), 1586–1593.
382. Tay, Y., Zhang, J., Thomson, A.M., Lim, B., Rigoutsos, I., MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 455 (2008), 1124–1128.
383. Tazawa, H., Tsuchiya, N., Izumiya, M., Nakagama, H., Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc. Natl. Acad. Sci. U.S.A. 104 (2007), 15472–15477.
384. Tront, J.S., Hoffman, B., Liebermann, D.A., Gadd45a suppresses ras-driven mammary tumorigenesis by activation of c-Jun NH2-terminal kinase and p38 stress signaling resulting in apoptosis and senescence. Cancer Res. 66 (2006), 8448–8454.
385. Tyner, S.D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C., Park, S.H., Thompson, T., Karsenty, G., Bradley, A., Donehower, L.A., p53 mutant mice that display early ageing-associated phenotypes. Nature 415 (2002), 45–53.
386. Tzatsos, A., Paskaleva, P., Lymperi, S., Contino, G., Stoykova, S., Chen, Z., Wong, K.K., Bardeesy, N., Lysine-specific demethylase 2B (KDM2B)-let-7-enhancer of zester homolog 2 (EZH2) pathway regulates cell cycle progression and senescence in primary cells. J. Biol. Chem. 286 (2011), 33061–33069.
387. Valadi, H., Ekstrom, K., Bossios, A., Sjostrand, M., Lee, J.J., Lotvall, J.O., Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9 (2007), 654–659.
388. Van Deursen, J.M., The role of senescent cells in ageing. Nature 509 (2014), 439–446.
389. Vasa-Nicotera, M., Chen, H., Tucci, P., Yang, A.L., Saintigny, G., Menghini, R., Mahe, C., Agostini, M., Knight, R.A., Melino, G., Federici, M., miR-146a is modulated in human endothelial cell with aging. Atherosclerosis 217 (2011), 326–330.
390. Vaziri, H., Dessain, S.K., Ng Eaton, E., Imai, S.I., Frye, R.A., Pandita, T.K., Guarente, L., Weinberg, R.A., hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107 (2001), 149–159.
391. Venkataraman, S., Alimova, I., Fan, R., Harris, P., Foreman, N., Vibhakar, R., MicroRNA 128a increases intracellular ROS level by targeting Bmi-1 and inhibits medulloblastoma cancer cell growth by promoting senescence. PLoS One, 5, 2010, e10748.
392. Ventura, A., Kirsch, D.G., Mclaughlin, M.E., Tuveson, D.A., Grimm, J., Lintault, L., Newman, J., Reczek, E.E., Weissleder, R., Jacks, T., Restoration of p53 function leads to tumour regression in vivo. Nature 445 (2007), 661–665.
393. Vickers, K.C., Palmisano, B.T., Shoucri, B.M., Shamburek, R.D., Remaley, A.T., MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat. Cell Biol. 13 (2011), 423–433.
394. Volinia, S., Calin, G.A., Liu, C.G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., Prueitt, R.L., Yanaihara, N., Lanza, G., Scarpa, A., Vecchione, A., Negrini, M., Harris, C.C., Croce, C.M., A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U.S.A. 103 (2006), 2257–2261.
395. Voller, D., Reinders, J., Meister, G., Bosserhoff, A.K., Strong reduction of AGO2 expression in melanoma and cellular consequences. Br. J. Cancer 109 (2013), 3116–3124.
396. Voorhoeve, P.M., Le Sage, C., Schrier, M., Gillis, A.J., Stoop, H., Nagel, R., Liu, Y.P., Van Duijse, J., Drost, J., Griekspoor, A., Zlotorynski, E., Yabuta, N., De Vita, G., Nojima, H., Looijenga, L.H., Agami, R., A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124 (2006), 1169–1181.
397. Vousden, K.H., Lu, X., Live or let die: the cell's response to p53. Nat. Rev. Cancer 2 (2002), 594–604.
398. Wada, T., Joza, N., Cheng, H.Y., Sasaki, T., Kozieradzki, I., Bachmaier, K., Katada, T., Schreiber, M., Wagner, E.F., Nishina, H., Penninger, J.M., MKK7 couples stress signalling to G2/M cell-cycle progression and cellular senescence. Nat. Cell Biol. 6 (2004), 215–226.
399. Wajapeyee, N., Serra, R.W., Zhu, X., Mahalingam, M., Green, M.R., Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell 132 (2008), 363–374.
400. Wang, E., Senescent human fibroblasts resist programmed cell death, and failure to suppress bcl2 is involved. Cancer Res. 55 (1995), 2284–2292.
401. Wang, W., Chen, J.X., Liao, R., Deng, Q., Zhou, J.J., Huang, S., Sun, P., Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence. Mol. Cell. Biol. 22 (2002), 3389–3403.
402. Wang, C., Jurk, D., Maddick, M., Nelson, G., Martin-Ruiz, C., Von Zglinicki, T., DNA damage response and cellular senescence in tissues of aging mice. Aging Cell 8 (2009), 311–323.
403. Wang, X., Liu, P., Zhu, H., Xu, Y., Ma, C., Dai, X., Huang, L., Liu, Y., Zhang, L., Qin, C., miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation. Brain Res. Bull. 80 (2009), 268–273.
404. Weber, J.A., Baxter, D.H., Zhang, S., Huang, D.Y., Huang, K.H., Lee, M.J., Galas, D.J., Wang, K., The microRNA spectrum in 12 body fluids. Clin. Chem. 56 (2010), 1733–1741.
405. Wei, S., Sedivy, J.M., Expression of catalytically active telomerase does not prevent premature senescence caused by overexpression of oncogenic Ha-Ras in normal human fibroblasts. Cancer Res. 59 (1999), 1539–1543.
406. Wei, W., Hemmer, R.M., Sedivy, J.M., Role of p14(ARF) in replicative and induced senescence of human fibroblasts. Mol. Cell. Biol. 21 (2001), 6748–6757.
407. Wei, W., Jobling, W.A., Chen, W., Hahn, W.C., Sedivy, J.M., Abolition of cyclin-dependent kinase inhibitor p16Ink4a and p21Cip1/Waf1 functions permits Ras-induced anchorage-independent growth in telomerase-immortalized human fibroblasts. Mol. Cell. Biol. 23 (2003), 2859–2870.
408. Wei, J.S., Song, Y.K., Durinck, S., Chen, Q.R., Cheuk, A.T.C., Tsang, P., Zhang, Q., Thiele, C.J., Slack, A., Shohet, J., Khan, J., The MYCN oncogene is a direct target of miR-34a. Oncogene 27 (2008), 5204–5213.
409. Wei, J., Shi, Y., Zheng, L., Zhou, B., Inose, H., Wang, J., Guo, X.E., Grosschedl, R., Karsenty, G., miR-34s inhibit osteoblast proliferation and differentiation in the mouse by targeting SATB2. J. Cell Biol. 197 (2012), 509–521.
410. Welch, C., Chen, Y., Stallings, R.L., MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 26 (2007), 5017–5022.
411. Weng, J.H., Yu, C.C., Lee, Y.C., Lin, C.W., Chang, W.W., Kuo, Y.L., miR-494-3p induces cellular senescence and enhances radiosensitivity in human oral squamous carcinoma cells. Int. J. Mol. Sci. 17 (2016), 1–10 article number 1092.
412. Whetstine, J.R., Nottke, A., Lan, F., Huarte, M., Smolikov, S., Chen, Z., Spooner, E., Li, E., Zhang, G., Colaiacovo, M., Shi, Y., Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell 125 (2006), 467–481.
413. Wightman, B., Ha, I., Ruvkun, G., Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75 (1993), 855–862.
414. Wu, G., Nomoto, S., Hoque, M.O., Dracheva, T., Osada, M., Lee, C.C., Dong, S.M., Guo, Z., Benoit, N., Cohen, Y., Rechthand, P., Califano, J., Moon, C.S., Ratovitski, E., Jen, J., Sidransky, D., Trink, B., DeltaNp63alpha and TAp63alpha regulate transcription of genes with distinct biological functions in cancer and development. Cancer Res. 63 (2003), 2351–2357.
415. Xiao, J., Lin, H., Luo, X., Wang, Z., miR-605 joins p53 network to form a p53:miR-605:Mdm2 positive feedback loop in response to stress. EMBO J., 30, 2011, 5021.
416. Xiong, Y., Hannon, G.J., Zhang, H., Casso, D., Kobayashi, R., Beach, D., p21 is a universal inhibitor of cyclin kinases. Nature 366 (1993), 701–704.
417. Xu, D., Takeshita, F., Hino, Y., Fukunaga, S., Kudo, Y., Tamaki, A., Matsunaga, J., Takahashi, R.U., Takata, T., Shimamoto, A., Ochiya, T., Tahara, H., miR-22 represses cancer progression by inducing cellular senescence. J. Cell Biol. 193 (2011), 409–424.
418. Xu, Q., Liu, M., Zhang, J., Xue, L., Zhang, G., Hu, C., Wang, Z., He, S., Chen, L., Ma, K., Liu, X., Zhao, Y., Lv, N., Liang, S., Zhu, H., Xu, N., Overexpression of KLF4 promotes cell senescence through microRNA-203-survivin-p21 pathway. Oncotarget 7 (2016), 60290–60302.
419. Xu, S., Huang, H., Li, N., Zhang, B., Jia, Y., Yang, Y., Yuan, Y., Xiong, X.D., Wang, D., Zheng, H.L., Liu, X., MicroRNA-33 promotes the replicative senescence of mouse embryonic fibroblasts by suppressing CDK6. Biochem. Biophys. Res. Commun. 473 (2016), 1064–1070.
420. Xue, W., Zender, L., Miething, C., Dickins, R.A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., Lowe, S.W., Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445 (2007), 656–660.
421. Yamakuchi, M., Ferlito, M., Lowenstein, C.J., miR-34a repression of SIRT1 regulates apoptosis. Proc. Natl. Acad. Sci. U.S.A. 105 (2008), 13421–13426.
422. Yan, L., Lee, S., Lazzaro, D.R., Aranda, J., Grant, M.B., Chaqour, B., Single and compound knock-outs of MicroRNA (miRNA)-155 and its angiogenic gene target CCN1 in mice alter vascular and neovascular growth in the retina via resident microglia. J. Biol. Chem. 290 (2015), 23264–23281.
423. Yang, J.S., Lai, E.C., Alternative miRNA biogenesis pathways and the interpretation of core miRNA pathway mutants. Mol. Cell 43 (2011), 892–903.
424. Yang, H.S., Alexander, K., Santiago, P., Hinds, P.W., ERM proteins and Cdk5 in cellular senescence. Cell Cycle 2 (2003), 517–520.
425. Yang, X., Feng, M., Jiang, X., Wu, Z., Li, Z., Aau, M., Yu, Q., miR-449a and miR-449b are direct transcriptional targets of E2F1 and negatively regulate pRb-E2F1 activity through a feedback loop by targeting CDK6 and CDC25A. Genes Dev. 23 (2009), 2388–2393.
426. Yang, S., Li, W.S., Dong, F., Sun, H.M., Wu, B., Tan, J., Zou, W.J., Zhou, D.S., KITLG is a novel target of miR-34c that is associated with the inhibition of growth and invasion in colorectal cancer cells. J. Cell. Mol. Med. 18 (2014), 2092–2102.
427. Yang, S., Wu, B., Sun, H., Ji, F., Sun, T., Zhao, Y., Zhou, D., Interrupted E2F1-miR-34c-SCF negative feedback loop by hyper-methylation promotes colorectal cancer cell proliferation. Biosci. Rep., 36, 2015, e00293.
428. Ye, Z., Fang, J., Dai, S., Wang, Y., Fu, Z., Feng, W., Wei, Q., Huang, P., MicroRNA-34a induces a senescence-like change via the down-regulation of SIRT1 and up-regulation of p53 protein in human esophageal squamous cancer cells with a wild-type p53 gene background. Cancer Lett. 370 (2016), 216–221.
429. Yi, R., Qin, Y., Macara, I.G., Cullen, B.R., Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 17 (2003), 3011–3016.
430. Young, A.R., Narita, M., Ferreira, M., Kirschner, K., Sadaie, M., Darot, J.F., Tavare, S., Arakawa, S., Shimizu, S., Watt, F.M., Narita, M., Autophagy mediates the mitotic senescence transition. Genes Dev. 23 (2009), 798–803.
431. Yu, Z.B., Li, Z., Jolicoeur, N., Zhang, L.H., Fortin, Y., Wang, E., Wu, M.Q., Shen, S.H., Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers. Nucleic Acids Res. 35 (2007), 4535–4541.
432. Zhang, G., Zhu, H., Wang, Y., Yang, S., Liu, M., Zhang, W., Quan, L., Bai, J., Liu, Z., Xu, N., Kruppel-like factor 4 represses transcription of the survivin gene in esophageal cancer cell lines. Biol. Chem. 390 (2009), 463–469.
433. Zhang, J., Sun, Q., Zhang, Z., Ge, S., Han, Z.G., Chen, W.T., Loss of microRNA-143/145 disturbs cellular growth and apoptosis of human epithelial cancers by impairing the MDM2-p53 feedback loop. Oncogene 32 (2013), 61–69.
434. Zhang, F., Cui, J., Liu, X., Lv, B., Xie, Z., Yu, B., Roles of microRNA-34a targeting SIRT1 in mesenchymal stem cells. Stem Cell Res. Ther., 6, 2015, 195.
435. Zhao, W., O'malley, Y., Wei, S., Robbins, M.E., Irradiation of rat tubule epithelial cells alters the expression of gene products associated with the synthesis and degradation of extracellular matrix. Int. J. Radiat. Biol. 76 (2000), 391–402.
436. Zhou, Q., Gallagher, R., Ufret-Vincenty, R., Li, X., Olson, E.N., Wang, S., Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23~27~24 clusters. Proc. Natl. Acad. Sci. U.S.A. 108 (2011), 8287–8292.
437. Zhou, Y., Hu, Y., Yang, M., Jat, P., Li, K., Lombardo, Y., Xiong, D., Coombes, R.C., Raguz, S., Yague, E., The miR-106b~25 cluster promotes bypass of doxorubicin-induced senescence and increase in motility and invasion by targeting the E-cadherin transcriptional activator EP300. Cell Death Differ. 21 (2014), 462–474.
438. Zhu, J., Woods, D., Mcmahon, M., Bishop, J.M., Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev. 12 (1998), 2997–3007.
439. Zindy, F., Eischen, C.M., Randle, D.H., Kamijo, T., Cleveland, J.L., Sherr, C.J., Roussel, M.F., Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12 (1998), 2424–2433.
440. Zovoilis, A., Agbemenyah, H.Y., Agis-Balboa, R.C., Stilling, R.M., Edbauer, D., Rao, P., Farinelli, L., Delalle, I., Schmitt, A., Falkai, P., Bahari-Javan, S., Burkhardt, S., Sananbenesi, F., Fischer, A., microRNA-34c is a novel target to treat dementias. EMBO J. 30 (2011), 4299–4308.